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Abstract 
Mechani sms of Tol erance to the Effects of C l o z ap ine and 
Pimo z ide on a Multiple Fixed Interva l  6 0 -second Fixed 
Rat i o - 3 0  Food Re inforcement Schedule in Rats . 
Heidi Freese Vil l anueva 
Virginia Commonwea l th Univers ity, 1 9 8 8  
Maj or Director : Dr . Joseph H .  Porter 
Thi s  study exam ined the behavioral and b iochemical 
vi i 
e f fects o f  two neuroleptic drugs . C l o z ap ine ( 1 0 mgjkg ) , an 
atyp i c a l  neurol epti c , and pimoz ide ( 1  mgjkg ) , a t ypical 
neurolept ic , were administered acutel y, chronica l l y  ( 1 0 
days ) , or i n  a behaviora l tol erance paradigm ( 9  days of 
post-session administration fol l owed by 1 0  days of 
presession administrat ion ) in order to assess the 
mechanisms of tolerance . Behaviora l e f fects were measured 
on a multiple FI 6 0 -second FR- 3 0  operant response schedu l e ;  
HPLC w a s  used to measure the biochemical e f fects o f  
c l o z ap ine in the b lood pl asma , frontal cortex and striatum . 
Presess ion administrat ion o f  c l o z ap ine and p imoz ide 
both produced initial d isruptions of response rate , 
response duration and rein forcement rate for both the FI 
and FR schedules , but onl y c l ozap ine disrupted the pattern 
o f  FI responding as measured by IOC . Tolerance developed to 
the e ffects of c l ozapine for FI schedule response rate , 
response duration and re inforcement rate measures and for 
the FR response durat ion measure . Tol erance did not deve l op 
to c l o z ap ine ' s  d is rupt ion of response and re inforcement 
vi i i  
rates on the F R  schedule ,  nor did tolerance deve l op to the 
d isruption of the IOC measure . Pimoz ide groups demonstrated 
an increasing sens itivity to the e f fects of the drug a fter 
repeated administrat ion for both FI and FR response rate , 
response duration and re inforcement rate . 
Post-sess ion administrat ion o f  c l o z apine and p imoz ide 
f a i l ed to disrupt operant respond ing and did not a f fect 
subsequent presess ion drug administrat ion . Thi s  suggests 
that both the tolerance to c l o z ap ine and the sens itivity to 
p imoz ide are medi ated by functional mechanisms . Repeated 
c l o z ap ine administration produces a behavioral tol erance 
whereas repeated pimoz ide administration produces a 
"behaviora l sens itivity" . 
Biochemical assays measuring the amounts o f  c l o zapine 
in the b l ood pl asma , frontal cortex and striatum con f irm 
that the tolerance to c l o z apine i s  not due to a 
d i spos i t ional mechanism ( i . e . , changes in drug metabol ism) . 
Assays revealed that quantities o f  c l o z apine did not d i ffer 
between the three c l o z ap ine groups , nor did c l o z apine 
d i f ferent i a l l y  a f fect the frontal cortex and striatum . 
I t  was concl uded that c l o z apine's response disrupt ing 
e f fects were not due to an anhedon ic e ffect , nor were the 
disrupt ing e ffects due to a motor deficit invo l ving a 
response terminat ion deficit . other motor deficits , 
however , were not discounted . Pimoz ide appeared to produce 
a pattern of d isrupt ion s imi lar to that produced by 
ext inction , thus suggest ing that anhedoni c  e f fects were 
invol ved . 
ix 
NEUROLEPTICS 
Beginning with the synthes is of a phenoth i a z ine cal led 
chlorpromaz ine i n  1 9 5 0 , drugs have been used to treat 
psychot i c  i l l nesses . Phenoth i a z ines , butyrophenones and 
th ioxanthenes are currentl y  used to manage and control the 
abnormal behaviors , auditory hal luc inations , and 
characteristic think ing disturbances that occur with 
sch i z ophren ia.  The most commonly prescribed neuroleptics 
are chlorpromaz ine , haloperidol , thiorida z ine , fluphenaz ine 
and tri fl uroperaz ine ( Burrows , Norman & Davies , 1 9 8 5 ) . More 
recently , l onger acting neurol eptics such as pimoz ide , a 
d iphenylbutylpiperid ine , have been developed . 
Neuroleptics genera l l y  i nterfere w ith dopamine 
transmi ss ion by blocking dopamine receptors and thereby 
cause the deve lopment of extrapyramidal motor s ide e f fects . 
Other s ide e f fects are a l so associated with neuro l eptic ' 
treatment , includ ing hyperpro lact inaemia and chol inergic , 
a-adrenerg ic and tryptam inerg i c  e f fects ( Tyrer , 1 9 8 2 ) . 
Other neuro l eptics that do not typ i ca l ly cause s ide 
e f fects , or produce l ess severe s ide e f fect s ,  are the 
' atyp i ca l ' benzamides ( sulpiride ) and d ibenz od i a z ep i nes 
( c l ozapine ) . 
S ide Effects 
Common centra l nervous system e f fects of neurolept ic 
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treatment include frequent s l ow ing of the EEG , sedat ion , 
worsening o f  psychotic symptoms with very h igh doses , and 
toxic confus ion , a c l oud ing of consc iousness that occurs 
with e lderly patients or w ith highly atrop inic agents 
( Tyrer , 1 9 8 2 ) . 
The most common s ide e ffects o f  neurol ept ic compounds 
are the extrapyramidal motor deficits . More than 3 0 %  of a l l  
patients rece i ving antipsychot ics w i l l  su f fer some side 
e f fects . Those drugs w ith l ittle chol inergic antagon ism 
w i l l  produce greater than 5 0 %  incidence of motor deficits , 
and the l ong-act ing depot drugs may have as high a s  8 0 %  
inc idence ( Knights e t  a l . ,  1 9 7 9 ) . Motor s ide e f fects 
assoc i ated with neuroleptic treatment may be acute or 
chroni c . 
Acute dys kinesias are the earl iest s ide e f fects , often 
occurring with i n  4 - 5  days of therapy and mani fest ing 
thems e l ves in the form of tort icol l i s  ( neck spasms ) , tongue 
contract ions , trismus ( spasms of the j aw muscles ) , 
oculogyric crises ( ro l l ing o f  the eye s )  and op isthotonos 
( spasms of the neck muscles)  ( Tyrer , 1 9 8 2 ) . Akathes ia , or 
motor restlessness , may occur a l so , perhaps due to the 
i nhibition o f  dopamine in the mesocortical pathways from 
the ventra l tegmentum to the frontal cortex (Van Putten , 
1 9 7 5 ) . The most common acute s ide e f fects are motor 
de ficits similar to those which accompany Parkinson ' s  
d isease ( Marsden , Mindham & Mackay , 1 9 8 1 )  invol ving 
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rigidity, tremor and bradykinesia , a s l owness in initiating 
and executing movements . 
The chronic e ffects o f  neurol epti c  treatment invo l ve 
tard i ve dyskines i a  (Macka y,  1 9 8 2 )  and general l y  occur in 
sch i z ophrenics on l ong-term phenothi a z ine or butyrophenone 
therapy ( Munkvad et a l . ,  1 9 68 ) . Tardi ve dyskinesia is a 
non-revers ible s ide e f fect , mani festing itse l f  i n  the form 
o f  the bucco-l inguo-mast icatory ( BLM) s yndrome which 
i n vo l ves purs ing and smacking the l ips , roll ing t he tongue , 
puf fing the cheeks , and l atera l , chewing j aw movements .  
I nc idence o f  tard i ve dyskines ia has been est imated to be as 
h igh a s  4 0- 5 0 %  (Ma rsden , Mindham & Mackay , 1 9 8 1 ) . 
Psychotropic agents have an a ff in ity for muscarinic 
receptors , especial l y  in relationship to the extrapyram idal 
s ide e f f ects . Those neurolept ics with the greatest 
muscarinic antagonism produce the fewest extrapyramida l ,  
s ide e f fects , whi l e  those w ith the lowest muscarinic 
antagoni sm have the highest incidence of motor s ide e f fects 
( M i l ler & H i l e y ,  1 9 7 4 ; Snyder et a l . ,  1 9 7 4 ) . The most 
potent antimuscarinic neurol eptics are t he ' atyp ica l ' 
neuroleptics such as cloz ap ine ; clozap i ne has t he l owest 
inc idence of Parkinsonism c l inica l l y  and a l so has a low 
potency for dopamine receptor blockade ( Fj a l l and , 
Christensen & Hyttel , 1 9 7 7 ) . 
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Neurochemical Act ions o f  Ant ipsychot ics 
The h igh correl at ion between the abi l ity of 
neuro l eptics to decrease psychoses and the devel opment of 
extrapyramidal s ide e f fects was one of the earl i est pieces 
of e vidence to support the hypothes is that the therapeut ic 
act i on o f  neurolept ics i s  dependent on the ir abi l ity to 
b lock centra l dopamine receptors (Mackay , 1 9 8 2 ; Joyce , 
1 9 8 3 ) . S ince Parkinson ' s  d i sease has been associated with a 
de f i c i ency in brain dopamine ( Hornykiewic z , 1 9 7 3 ) , the 
motor de f i c its produced by neurol epti c  treatment suggests 
that neurol eptics block dopamine receptors . Screening 
techni ques for new ant ipsychot ic compounds are genera l ly 
based on the deve lopment of motor de ficits and on t he 
abi l ity of the compounds to antagon i z e  dopamine agon ists 
( Kl awans , 1 9 7 3 ) . For examp l e , neuroleptics may inhib it 
apomorphine and amphetamine- induced stereotypies ( Munkv�d , 
Pakkenberg & Randrup , 1 9 68 ) . Neuroleptics a l so produce an 
e l e vation in homovani l l ic acid ( HVA ) , suggesting an 
acceleration in the turnover of dopamine ( Nyback , Sedva l l , 
& Kopin , 1 9 6 7 ; O ' Keefe , Sharman , & Vogt , 1 9 7 0 ) . Further 
e vidence for the ant idopaminergic actions of neuroleptics 
is presented by the hyperpro l act inaemia wh ich i s  a "ma j or 
a nd consistent e ffect " ( Meltzer & Fang , 1 9 7 6 ;  Gruen et a I , 
1 9 7 8 ; Nathan et a l . , 1 9 8 1 )  caused by neurol ept ic treatment . 
Tunerinfundibular dopamine i s  known to inhibit pro l actin 
secretion ; there fore , if dopamine i s  b l ocked , prol actin 
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secretion increases , resulting in hyperprol act inaemia . 
Cloz apine , however , does not increase pro l actin secret ions , 
suggesting t hat c l o z ap ine does not a f fect the 
tuberoinfundibul a r  dopamine system . Burrows and c o l l eagues 
( 19 8 5 )  suggest t hat c l oz ap ine a f fects the meso l imb ic 
dopamine system , rather t han tuberoinfund ibular dopamine . 
Another t heory o f  schi z ophrenia suggests that 
serotonin and norepinephrine p l ay important roles in 
schi z ophrenia ( Gaddum , 1 9 5 4 ; Wool ey & S haw , 1 9 5 4 ; ste i n  & 
Wise , 1 9 7 1 ; Mason , 1 9 8 1 ; ) . This theory i s  based on t he 
f i nding t hat t he p ha rmacological e f fects o f  reserp ine 
para l l e l  t he curve of depletion and restorat ion of bra in 
serotonin content over t ime ( Hess et a l . ,  19 5 6 )  and that 
t he p harmacological and c l inical e ffects of the drug appear 
to be i nversely proport ional to the· abi l ity of bra in 
t issues to restore serotonin and norepinephrine to t he i r  
storage s ites ( Brodie e t  a l . ,  1 9 6 6 ; Glowinski , Iversen & 
Axe lrod , 1 9 6 6 ) . 
Typical vs . Atypical Neurolept ics 
Pimoz ide . Pimoz ide i s  t he purest dopamine antagon i st 
ava i l able . A diphenylbutylpiperadine , pimoz ide i s  a l ong 
act ing ant ipsychotic agent ( Tyrer , 1 9 8 2 ) . Peak plasma level 
is reached 3 - 6  hours a fter administrat ion , with a rap id 
dec l ine a fter t hat time . Pimoz ide has a l ong ha l f- l i fe . The 
hal f-l i fe i s  5 6  hours in rat l iver , b lood and bra i n , 2 4 - 4 8  
5 
hours in schi z op hrenic humans , and approximately 1 8  hours 
in t he p lasma o f  hea l t hy human volunteers . Whi l e  t he 
e f fectiveness o f  p imoz ide i s  sustained for 6 . 5  to 9 hours , 
t he drug i s  s t i l l  detectable in t he plasma of 
schi z ophrenics a fter 1 4  days ( Pinder et a l . ,  1 9 7 6 ) . 
Pimo z ide produces a very high inc idence o f  tard ive 
dyskinesia ( Burrows et a l . ,  1 9 8 5 ) , a f fect ing approximate ly 
1 5 %  of t hose rece iving p imoz ide for severa l mont hs . 
Pimo z ide antagoni z es hypoprol actinaemia , hyperthe rmia and 
eme s i s  with l ittle e f fect on the l evels of endogenous 
norepinephrine and st imul ates dopamine turnover , perhaps by 
b l oc king central dopamine receptors . Pimoz ide produces l ow 
intensity catalepsy and 0 . 5- 2 . 5  mg/ kg i . v .  produces m i l d  
sedat ion in baboons , but general l y  pimoz ide has few 
sedative properties ( Pinder et a l . , . 1 9 7 6 ) . 
I ntracrani a l  sel f-st imul at ion i s  inhibited by p imo�ide 
( ED5 0  = 0 . 2 2 mg/ kg lop . ) ( Pinder et a l . , 1 9 7 6 ) . Thi s  
i n hibition o f  sel f -stimulat ion in the nuc l eus accumbens and 
mesencepha lon by p imoz ide appears to be due to pimo z ide ' s  
e f fects on t he dopamine and norepinephrine systems ( Liebman 
& Butche r ,  1 9 8 4 ; Phi l l ips , Brooke & Fibige r ,  1 9 7 5 ) . This 
inhibi t ion i s  comp l etely abo l i s hed by the centra l ly acting 
anti c ho l inergic dexetrimide (Wauquier & Niemegeers , 1 9 7 5 ) . 
Whi l e  p imoz ide produces a minimal increase in cerebra l 
turnover o f  norepinephrine , it does not block t he cAMP 
response to norepinephrine in the l imb ic forebra in 
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( Bl umberg , Taylor & Sulser , 1 9 7 5 ) . Pimoz ide sel ectively 
b locks dopamine and i ncreases dopamine turnover ,  but has 
very l ow a ant i c ho l i nerg i c  potency ( Pi nder et a l . , 1 9 7 6 ) . 
Pimo z ide antagoni z es amphetamine and apomorphine ; 
Whi l e  some studies have s hown t hat tolerance has developed 
to amphetamine and apomorphine antagoni sm in anima l s , this 
e f fect has not been demonstrated c l inica l ly ( Niel sen et 
a l . , 1 9 7 4 ) .  Tolerance does not devel op to the ant ipsychot ic 
e f fects o f  p imoz ide ( Pinder et a l . , 19 7 6 ) . 
Clo z apine. Clo z ap ine is an atypical neurolept ic with 
strong powerful ant i c ho l i nergic propert ies ( Gruen et a l , 
1 9 7 8 )  and produces few extra-pyramida l s ide e f fects ( Gross 
& Langer , 1 9 6 6 ; Matz et a l . , 1 9 7 4 ; S impson & Varga , 1 9 7 4 ) . 
Clo z ap ine produces increases i n  HVA in the corpus striatum 
and even more so i n  the l imbic system ( Barthol i n i  et a I "  
1 9 7 2 ; Anden & Stock e t  a l . , 1 9 7 3 ) .  The hal f-l i fe o f  
c l o z ap i ne i s  about 6 hours i n  rats , with a steady state 
reached a fter 6 - 1 0  days of chron ic drug administration 
( Ac kenhe i l  & Hippius , 1 9 7 7 ) .  
The kinetics of c l o z ap ine i n  t he bra in para l l e l  that 
i n  t he p l a sma , as evidenced by pos itron emiss ion tomography 
( PET)  in t he rhesus monkey. The highest uptake of c l o z apine 
i s  measured i n  t he striatum and the mesencepha l on , regions 
w i t h  a high dens i ty of dopamine receptors . Pretreatment 
with N-methy l -spiperone , a dopamine receptor antagon ist , 
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does not a f fect uptake ; however , high doses of clo zapine 
a lter N -methyl-sp iperone binding , suggesting that c l ozapine 
and N-methy l -spiperone compete for t he same receptor 
popu l at ion in t he striatum ( Hartvig et a l . ,  1 9 8 6 ) . 
Cl o z ap ine , however ,  does not selectively a ffect dopamine 
receptors . Cl oz apine ' s  a f finity for non-dopamine receptors 
( acetyl c ho l ine , seroton in , histamine , norepinephrine ) i s  
comparable to or greater t han i t s  a ffinity f o r  dopami ne 
receptors ( Leysen , 1 9 8 2 ) . Whil e  c l ozapine i ncrea ses 
extrace l lular l evels of d i hydroxyphenyl aceti c  acid ( OOPAC) 
in the striatum and t he nucleus accurnbens , it a l so produces 
a decrease in 5-HlAA extracel lu l arly in t hese regions , 
suggesting t hat clozap ine acts on t he metabol ism of both 
serotonin and dopamine in t he region of t he nucleus 
accurnbens (Ma idment & Marsden , 1 9 8 7) . 
striatal 0-2 receptors are not a ltered by c l ozapioe ,  
but striatal 0- 1 receptors may be b locked , a s  wel l  as 
striatal c hol inergic receptors . Rupniak et a l . ( 1 9 8 5 )  
compared t he e f fects o f  c hronic c l o z apine ( 2 4 - 2 7  mgjkgjday) 
and ha loperidol ( 1 . 4 - 1 . 6  mgjkgjday) on striatal receptors 
in rats by administering the neuroleptics in t he anima l s ' 
drinking water for up to one year . Whi l e  ha l operidol 
b locked the 0-2 receptors but not the 0- 1 receptors in the 
striatum , c l o z apine did not a lter the striatal 0- 2 receptor 
function but did bl ock t he 0- 1 receptors . The high 
ant ichol inergic activity of c l ozapine is bel ieved to 
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protect against t he emergence o f  striatal dopamine receptor 
supersens i t iv ity ( M i l l er & H i l ey ,  1 9 7 4 ; Snyder ,  Greenberg & 
Yamamura , 1 9 7 4 ) . Chronic hal operidol treatment produced 
exaggerated stereotypical responses to apomorphine , an 
increase in striatal 3 H-spiperone binding , and an increase 
in striatal a cetylcho l ine concentration cons istent with 
previous reports o f  the e f fects o f  typical neuroleptics 
( Cl ow ,  et a l . ,  1 9 8 0 ; Maniga iah,  et a l . ,  1 9 8 2 ) . 
Tol erance 
One of t he most common changes produced by prior 
e xperience with a drug is a decreased respons iveness to its 
e f fectiveness , or tolerance . As an organ ism acquires 
tolerance , it becomes l es s  sens itive to the act ions o f  the 
drug . The devel opment o f  tolerance compl icates the use o �  
drugs in t herapeuti c  conditions t hat requ i re repeated 
administration of t he drug ( Schuster , 1 9 7 8 ) . Tolerance is a 
common b i o l ogical phenomenon which develops to phys ical 
conditions as wel l  a s  to drugs ; e . g . , tol erance has been 
s hown to develop to heat , col d ,  electric s hock, exerc i se , 
and to t he e f fects of many bra in les ions . ( Dews , 1 9 7 8 ) . 
Pharmacologica l ly , tolerance i s  described a s  a 
diminished e f fect occurring with success ive administration 
o f  t he same dose such that a higher dose of t he drug i s  
required to produce the original intensity and/or duration 
o f  action o f  t he drug . Tol erance may be def ined and 
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quanti fied by determining the dose response rel a t i ons hip 
be fore and a fter repeated exposure to a drug ( Schuster , 
1 9 7 8 ) . A para l l e l  s hi ft to t he right of t he dose response 
curve indicates t he development of tolerance ( Dews , 1 9 7 8 ) . 
Tol erance may be categorized as either d ispositional 
( metabo l i c )  or functional ( cel lular) . Dispos itional 
tolerance results when t he p hys iochemical processes 
handl ing t he drug are mod i f ied so t hat a decreased 
concentration o f  t he drug reaches the receptors ( De ws ,  
1 9 7 8 )  by decreas i ng t he e ffect ive concentrat ion o f  the 
agonist at t he s ite o f  act ion , by reducing the normal 
reactivity of t he receptors , or by chang ing the response 
e l ic i ted due to homeostatic mecha ni sms ( Feldman & Quenzer , 
1 9 8 4 ) . The resul t ing decrease in sens i t ivity to the drug 
may be due to a ltered absorpt ion or·distribut ion of the 
drug , to inactivat ion via increased b i nding to an inert , 
complex , or to an increased rate of e l iminat i on of t he 
substance ( Sc huster , 1 9 7 8 ) . Dispos it ional tol e rance may 
produce a 1/ 2 l og shi ft of t he dose response curve ; rarely 
i s  t here greater t han a 2 - 3  fold increase i n  sen s i t iv ity 
with d ispos i tional tolerance ( Dews , 1 9 7 8 ) . 
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Functional tolerance involves t he devel opment o f  
tolerance t o  behavioral a nd envi ronmenta l variables 
( Krasnegor , 1 9 7 8 ) . Functiona l tolerance i s  an adaptation to 
some.drug-induced physiol ogical perturbat ion and is used to 
describe tolerance that occurs when the concentrat ions of 
drug a t  targets s ites in tolerant and non-tolerant 
organ i sms are equal ( Schuster ,  1 9 7 8 ) . Funct ional tolerance 
may be p ha rmacodynamic or behavi ora l .  Pharmacodynamic 
tolerance describes a change in receptors or funct iona l ly 
rel ated cel l s  such t hat t he e f f icacy o f  t he drug dose i s  
reduced , even t hough the cel l s  a re subj ected to the same 
concentrat i on of drug . This tolerance cannot be exp l a ined 
on t he bas i s  o f  a ltered metabol ism or a l tered 
concentrat ions of the drug reaching the bra in ,  but may be 
due to a c hange in the receptors t hemselve s ,  perhaps a 
c hange i n  t he number receptors or i n  the i r  a f f i n ity for the 
drug ( Fe ldman & Quenzer , 1 9 8 4 ) . A 1 0 - fold increase ( 1  l og 
unit s hi ft to the right o f  t he dose response curve ) in 
sens i tivity may occur with pharmacodynamic tolerance ( Dews , 
1 9 7 8 ) .  Behavioral tol erance i s  the result of a change i n  
e f f i cacy o f  t he drug due t o  a n  al teration of env i ronmen�a l  
constra ints ; i n  other words , " the subj ects learn t o  cope 
with t he e ffects of the drug" ( Dews , 1 9 7 8 ) . No clear 
consensus exists as to whether behavioral tolerance 
represents t he devel opment o f  tolerance to the behav ioral 
e ffects of a substance , or t he e f fects o f  behavior on the 
devel opment o f  tolerance to the substance ' s  e f fects 
( Krasnegor , 1 9 7 8 ) . Theories of behav ioral tolerance inc lude 
class ica l cond itioning ( S iegel , 1 9 7 8 ) , stress ( Carder , 
1 9 7 8 )  and operant theories (Woolverton , 1 9 7 8 ; Ferraro , 
1 9 7 8 ; Schuster ,  1 9 7 8 ) . 
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The ideal way to d iscriminate between d isposit ional 
and functional tolerance i s  to determ ine whi c h  doses of a 
drug produce t he same concentrat ions i n  t he bra ins of 
tolerant and non-tolerant anima l s .  If t he concentrat ions 
a re equa l ,  tolerance must be due to some funct ional change 
in t he organ i sm. I f  t here is a decreased concentrati on i n  
t he tolerant anima l s , some tolerance must be due to 
decreased drug respons iveness caused by d ispos i tional 
c hanges .  To rul e  out t he i nvolvement of concurrent 
funct ional changes , a tolerant animal may be g iven a higher 
dose of drug suffi cient to produce a concentration of drug 
in t he bra i n  t hat is equal to t hat of a non-tol erant 
anima l . Only if both groups a re equal l y  respons ive may it 
be concluded t hat t he tol erance i s  entirely attributed to 
d i spos itional factors ( Schuster , 1 9 78 ) . 
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Behavioral tol erance should be identi f ied by pos i t i ve 
criteri a ,  not by exclus i on , s ince t he various mechanisms of 
tolerance are not mutual ly exclusive ( Dews , 1 9 78 ) . To study 
behaviora l tolerance , t he behavior must be quant i fi abl e and 
must rema i n  stabl e  over l ong periods of t ime ( S c huster , 
1 9 78 ) . Operant condition ing procedures are ideal for the 
study o f  both acute and c hronic e f fects o f  drugs because 
operant basel ines which remain stable over periods o f  
months and years have been produced ( Ferster & S kinner , 
1 9 5 7� Dews , 1 9 77 ;  Thompson & Schuster , 1 9 6 8 ; Se iden & 
Dykstra , 1 9 77) . Also , a wide range of behaviors can be 
brought under experimental control and measured prec i sely , 
making t he method extremel y  valuable for t he study of drug 
tolerance . 
An a lternat ive to d i rectly measuring bra in 
concentrations involves t he use of operant cond ition ing 
procedures . A change in a drug ' s  d i spos ition in the body 
s houl d  produce comparable c hanges in response to a l l  
behaviora l actions o f  the drug . I t  i s , howeve r ,  unl i kely 
t hat functional tolerance would devel op at the same rate or 
to t he same extent to a l l  o f  a drug ' s  behavioral actions . 
There fore , demonstrat ing the d i f ferent ial devel opment of 
tolerance to various behaviora l e f fects of a drug would 
suggest t hat t he mechanism i s  functional .  The demonstration 
of t he devel opment o f  funct ional tolerance is dependent on 
selecting t he right behaviora l measures . I f  funct ional 
tolerance develops to a l l  of the behavioral measures ta k�n , 
it i s  impossible to d i f ferent iate between funct ional and 
d i spos itional tolerance . A powerful strategy used in this 
case i s  a multiple schedule o f  re inforcement ( Schuster ,  
1 9 7 8 ) . For example , Schuster et a l . ( 19 6 6 )  used a multiple 
f ixed interval ( FI ) - d i f ferenti a l  rate o f  l ow respond ing 
( DRL) schedule to s how t hat d i f ferenti a l  tolerance devel ops 
with amphetamine ; response rates increased under t he DRL 
schedule , but no changes were seen with FI response rates . 
. I t  has a l so been demonstrated that behavioral 
tolerance devel ops only when the disruptive e f fects of the 
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d rug produce a decrease in re inforcement frequency . 
Tolerance has been shown to devel op to rate increasing 
e ffects o f  a drug on DRL schedules ( S chuster & Z immerman , 
1 9 6 1 )  and to the rate decreasing e ffects o f  a drug on an FI 
schedule only if the drug decreases respond ing enough to 
decrease the frequency of re inforcement ( S chuster et a l . ,  
1 9 6 6 ) . No tolerance devel oped to the rate increasing 
e f fects o f  amphetamine when rats were tra ined to l ever 
press every 3 0  seconds to avoid a shock ( S chuster et 
a l . , 1 9 6 6 ) . Thus , "behavioral tolerance w i l l  develop in 
those a spects of the organism ' s  behaviora l repertoire where 
the action of the drug is such that it disrupts the 
organism ' s  behav ior in meet ing t he environmenta l 
requ irement for re in forcements . Conversely , where the 
act ions o f  the drug enhance , or do not a f fect , the 
organ i sm ' s  behavior in meet ing re in forcement requi rements , 
we do not expect to development o f  tolerance . "  ( Schuster , 
1 9 7 8 , p . 1 3 )  
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The development of tolerance is dependent on both the 
t ime and the frequency of drug administration ; and more 
than one type of tol erance can develop to the behav ioral 
act ions o f  the same drug . Various stud ies ( Campbe l l  & 
Seiden , 1 9 7 3 ; Schuster et a l . ,  1 9 6 6 ; Schuster & Z immerman ,  
1 9 6 1 )  have demonstrated that i f  amphetamine i s  g iven daily 
to rats or monkeys immed iately prior to respond ing on a DRL 
schedul e  of food reinforcement , tol erance deve lops to the 
e f fects o f  the d rug . However, when the d rug i s  given 
chroni ca l l y  a fter the sess ion , no tolerance develops to the 
behavioral act i ons of the d rug , suggesting an interaction 
between the d rug and the env i ronment . But when rhesus 
monkeys were given twice dai l y  inj ections of d-amphetamine 
in gradual ly increas ing doses ( Se iden et a l . ,  1 9 7 6 ) , 
tolerance developed to the d i s ruptive action o f  the drug , 
e ve n  thought they d i d  not perform the behavi oral task 
during the d rug regimen. Thi s  procedure resulted in an 
i rrevers ible depletion of bra i n  monoamines not seen when 
l ower doses of d-amphetamine a re given once d a i ly . 
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A tolerance study by Carlton and Wolgin ( 19 7 1 )  found 
that when rats were tested for the amount of m i l k  consumed 
during chronic amphetamine administration , the rats 
rece iv i ng amphetamine before the test session devel oped 
tolerance to the anorexic e ffects of amphetamine whi l e  
those receiv ing post-sess ion inj ections d i d  not deve lop 
such tolerance . When post-sess ion subj ects were switched to 
pre-sess ion administration , no initial tolerance was 
demonstrated , despite the fact that the anima l s  had been 
rece iving daily amphetamine inj ections a fter the prev ious 
test session . In a study of tolerance to the analgesic 
e f fects o f  morphine , S i egel ( 19 7 6 )  found that rats 
rece iving morphine in the test env i ronment exh ib ited 
tolerance e f fects whi l e  anima l s  receiving morph ine in the 
home cage did not exh ibit tolerance in the test ing 
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situation . 
Tol e rance has been shown to the motor e f fects of some 
neuroleptic d rugs , genera l ly the atyp ical compounds , but 
tolerance has rarely been shown to the ant ipsychot ic 
e f fects o f  the d rugs ( Pinder et a l . ,  1 9 7 6 ) . st i l l e , et al . 
( 19 7 1 )  compared haloperidol and c l o z ap ine in a chronic 
dos i ng study of motor act iv ity and found that haloperidol 
decreased activity for the enti re 1 9  days whi l e  the 
c l o z ap ine anima l s ,  a fter showing an initial decrease in 
activity , recovered from the e f fects of the drug by day 5 
and even increased activity above basel ine l evel s  for the 
next 1 4  days . Further studies ( F reese , Porter, Bj ornsen and 
Kaemp f ,  1 9 8 4 ; Kaempf & Porter, 1 9 8 7 ) conf i rmed these 
results . Chl o rpromaz ine , c l o z ap ine and p imoz ide have a l l  
been tested in chroni c  dos ing stud ies of motor activity �o r 
a s  l ong as 3 8  days , and animal s  receiving c l o z apine 
developed tolerance to the e f fects o f  the d rug with i n  ten 
days . No tolerance developed to the e f fects of the typical 
neuroleptic chl o rproma z ine ove r  the ent i re chronic dosing 
period . Tolerance did devel op to p imoz ide on one measure of 
motor activity ( see Kaemp f & Porter, 1 9 8 7 ) , however the 
subj ects in this study were only tested on motor activity 
at the beginning and the end of the study , and no tolerance 
devel oped to the e f fects of p imoz ide in the operant 
proc�dures used in thi s  study . Two othe r studies have a l so 
shown that tolerance may develop to the e f fects of 
p imo z ide . Graml ing , Fowler and Col l ins ( 19 8 4 )  s impl y  
measured the number o f  t imes rats l icked a 3 2% sucrose 
solut ion , whi l e  Graml ing , Fowle r  and T i z z ano ( 19 8 7 ) used a 
l ever press i ng paradigm o f  continuous re inforcement with 
rats responding for sucrose re in forcement . Both stud ies 
showed t rends toward recovery under the e f fects of pimoz ide 
a t  a dose of 0 . 25 mg/kg . One important d i f ference between 
the Graml ing et a l e  studies and studies that have f a i led to 
show tolerance to p imoz ide is that Graml ing et a l e  used 
non-deprived rats .  
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Tol e rance has a l so been shown to develop to the rate 
decreasing e f fects of neuroleptics in operant sett ings . 
Clozapine- induced d i s rupt ion of barpress ing for food reward 
d iminishes within ten days on both a multiple random 
interva l schedul e  (Vi l l anueva & Porter, 1 9 8 7 a , b )  and on -an 
F I  6 0 - sec schedule ( Kaempf & Porter, 19 8 7 ) ; p imoz ide 
d i s rupts barpress ing for the ent i re period of drug 
administration on both these schedules . Interesting l y ,  
p imoz ide does not d i s rupt the pattern of FI respond ing 
( Kaemp f & Porter, 19 8 7 ) . 
RATIONALE 
Previous studies attempting to ident i fy the mechanisms 
of tol e rance to c l o z ap ine with a multiple random inte rval 
schedu l e  have produced equ ivocal results (Vi l lanueva & 
Porter, 19 8 7b ) . Whi l e  the maj ority o f  the data suggest that 
the tolerance is due to pharmacodynamic mechanisms , there 
i s  some evidence to suggest that a behav iora l  in fluence may 
be present . To further assess thi s  problem , acute and pre­
and post-sess ion chronic administrat ions of neuroleptics 
prior to a multiple operant schedule were fol l owed by 
b i ochemical assays o f  the frontal cortex , striatum and 
b lood p l a sma to determine whether bra in and b l ood 
concentrations of these d rugs d i f fered a fter acute or 
chronic dos ing . 
Prev ious discrepanc ies regarding results based on 
response rates ( see Wis e ,  19 7 8 ; Ettenberg et a l . ,  19 7 9 )  
have prompted suggest ions that other measures o f  operant 
responding may be necessary to eva luate the e f fects o f  
neuro l eptic compounds .  Fowler,  F i l ewich & Leberer ( 19 7 7 )  
have suggested that response duration may prov ide a more 
e ffect ive ind i cation of the motor e f fects o f  neurolept ics . 
Response duration has been shown to be influenced by 
exti nct ion ( Notterman & Mint z , 19 6 5 )  and by some d rugs 
( Fowl er ,  et a l . ,  19 7 7 ) ,  and may provide behavioral 
informat ion that is not ava i l able from response rate a l one 
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( Wa l ke r  et a l . ,  1 9 8 1) . A comparison by Faustman and Fowler 
( 19 8 1 )  o f  haloperidol and extinction on a f ixed interval 
ten-second schedu l e  has shown that response rates for the 
two conditions a re s i m i l a r ;  however, when response 
durations a re measured , hal operidol has been shown to 
p roduce l onger durat ions than ext inction . Response durat ion 
may there fore provide a d i fferenti a l  measure o f  the motor 
e ffects of neurol eptic d rugs . 
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I ndex of curvature ( IOC ) is an ideal measure for 
studying the e ffects of d rugs on f i xed interval 
responding . F ixed- interval schedules produce cha racteri stic 
response patterns in which a n  initial pause occurs at the 
beginning of each interva l ,  fol l owed by respond ing that 
accel e rates to a high rate which is ma inta ined unt i l  
re i n forcement occurs ( Fry ,  Kel l eher· & Cook , 19 6 0 ) , 
resulting in a characteristic curve cal l ed the " F I  
sca l l op " . I t  i s  poss ible t o  calcul ate the extent and 
d i rection to wh ich this curve deviates f rom a stra ight 
l ine ; this measure is cal l ed the index of curvature . The 
extent is determined by compa ring the a rea under the curve 
w ith the a rea under the stra ight l ine . The d i rection i s  
determined such that a negative l y  acce l e rated curve w i l l  
produce a negative IOC value whi l e  a pos itively accel e rated 
curve w i l l  produce a pos itive IOC value . The min imum and 
maximum values of the IOC a re dependent on the number of 
subdivis ions of the f ixed interval .  Whi l e  the max imum va lue 
for four interva l s  i s  0 . 7 5 ,  the maximum value for ten 
interval s  is 0 . 9 0 .  When responses a re emitted at a constant 
rate , the IOC i s  z e ro .  
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The IOC has a number o f  advantages over measurement of 
s impl e  response rates . For example , chl o rproma z ine has been 
found to have incons istent e ffects on the response rates of 
p igeons on the F I  10 -min components o f  a multiple F I  10 -min 
FR 3 0  schedul e  of re inforcement ( Fry et a l . ,  19 6 0 ) . The 
e ffects on the IOC , however, a re consistent , indicating 
that chl o rpromaz ine tends to e l iminate the curvature such 
that the p igeons respond at a relatively constant rate 
throughout each i nterval .  other i nvestigators ( Kaemp f & 
Porter,  1 9 8 7 ) , us ing pimoz ide on a FI 6 0 -sec schedule , 
found that whi l e  p imoz ide d i s rupted response rates , the 
pattern of responding was not d i s rupted as evidenced by the 
lack o f  change in the IOC . 
I n  the present study a mul t iple schedule ( FI 6 0 -sec FR 
3 0 )  was employed to compare the e f fects of typical and 
atypical neuroleptics and to explore the d i f ferential 
development o f  tolerance to these compounds . Both p imoz ide , 
a typical neurolept ic , and cloz apine , an atyp ica l 
neurolept i c  were assessed on a multiple FI 6 0-sec FR 3 0  
schedu l e  to determine d i fferences between the two drugs . 
Leander ( 19 8 3 ) has found that typical and atypical 
neurolept ics produce d i f ferent patte rns of d i s rupt ion in 
p igeons on a MULT FI 5 -min FR 30 schedule . Typ ica l 
ant ipsychot ics were found to decrease the response rate 
more on the FI schedule than on the FR schedul e , whi l e  
c l o z apine decreased responding o n  both schedules at doses 
of 1 . 25 and 2 . 5 mg/kg . Leander did not , however , ut i l i z e  
the Ioe to determine whether the pattern of responding was 
d i srupted by neuroleptic drugs . Beca use acute doses of 
typical a nd atypical neuroleptics genera l l y  produce no 
d i f ferences on response rate measures , both the s imple 
response and reinforcement rates and response durat ion and 
i ndex of c urvature were analyzed . 
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GENERAL METHOD 
Subjects 
S ixty adu l t  male Sprague-Dawley a lbino rats 
( approximately 25 0 g )  from Dominion Laboratories served as 
subj ects for these experiments .  Subj ects were individua l ly 
housed in an animal colony room ( 22°C ) with a 12 hour 
l ight : dark cycle ( 6  am to 6 pm ) .  Water was continuous ly 
ava i l ab l e  in the home cage. Body we ights were ma inta ined at 
approximately 8 0 %  of free- feeding we ight by restrict ing 
d a i ly food rat i ons ( AGWAY MRH 3 0 0 0 ) . 
Apparatus 
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Operant sessions were conducted in four BRS/LVE 
operant chambers ( Model 020 )  housed in sound attenuated 
cub i c l e s .  Bio Serv food pe l l ets ( 4 5  mg ) were del ivered by, a 
BRS/ LVE pel l et dispenser to a food cup l ocated in the 
center of the int e l l igence pane l .  A response l ever was 
l ocated to the left of the food cup. 
Operant sessions were conducted in a darkened room 
with masking noise and vent i l at ion provided by fans. S o l i d  
state programming equipment l ocated in an adj acent room 
contro l l ed operant sessions and recorded data. 
Drugs 
Pimo z ide ( Janssen Pha rmeceut ica , Bel gium )  was 
dissolved in distil l ed water with approximately 10 drops o f  
8 5 %  l actic a c id p l u s  0 . 5  ml Tween 8 0  ( Polyoxyethyl ene 
Sorb itan Mono-Ol eate ) to a concentration of 1 . 0 mg/ml . 
Clozapine ( S ando z , New Jersey ) was disso lved in d i st i l l ed 
water w ith approximately 1 0  drops o f  8 5 %  l actic acid to a 
concentrat ion o f  1 0 . 0  mg/ml . Al l inj ections includ ing 
veh i c l e  were administered intraperitoneal l y  in volumes of 1 
ml/kg body we ight . Clozapine and veh icle inj ections were 
administered one hour prior to operant sess ions , wh i l e  
p imoz ide was admin istered four hours prior t o  operant 
sess ions . 
Tra i n ing 
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Rats were maga z ine tra ined beg inning 24 hours a fter 
the initiat ion of food deprivat ion . For three days the 
animals were a l lowed to consume one gram of the Bio Serv , 
food pel l ets from the food cup in the operant box with no 
l ever present in the box. Th is was fol l owed by three days 
of automatic pel l et del ivery eve ry thirty seconds for a 5 
m inute period , again with no lever present in the box . 
Anima l s  were then auto shaped to ba rpress on a f ixed rat io 1 
( FR 1) schedule for three train ing sessions . Any rats that 
did not acqu i re the barpress response were manual ly trained 
by the method o f  successive approximation . A ten minute 
session of gradua l ly increas ing fixed interval requi rements 
was then introduced , with the inte rval requi rements 
increasing from FI 4 -sec to FI 6 0-sec . Anima l s  rema ined on 
the FI 6 0-sec schedule for 2 1-minute sessions unt i l  
response rates and index of curvature ( I DC )  were stable . A 
multiple ( MULT ) schedule was then introduced . Thi s  schedu l e  
consisted o f  three seven-minute FI 6 0-sec components and 
three three-minute FR components ( accompanied by a 
d iscriminat ive st imulus tone o f  18 0 0  H z )  that a l ternated 
during a thirty minute session . The FR schedule was 
gradual ly increased from FR 5 to FR 3 0 .  Thus , the final 
schedule was a MULT FI 6 0-sec FR 30 food reinforcement 
schedul e .  House l ights were i l luminated during the thi rty 
minute session and were ext inguished at the end of each 
sess ion . 
Procedure 
Fol l owing tra ining and stab i l i z at ion of respond ing op 
the MULT FI 6 0-sec FR 30 schedule , subj ects were matched 
for response rates from both FI and FR components and 
randomly ass igned to one of seven experimental groups : 
Group 1- VEHICLE ( N  = 7 ) - These rats served as controls for 
both the behavioral data and for the HPLC assays . 
These rats rece ived inj ections o f  the vehicle one hour 
prior to operant sessions and one hour a fter operant 
sess ions for 19 consecut ive days . Immed iately 
fol l owing the 19th operant session six o f  these rats 
( se lected randomly ) were k i l l ed and t issue col l ection 
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a nd assays were performed . 
Group 2- CHRONI C  PRESESS ION CLOZAPINE ( N  = 9 ) - To assess 
the behaviora l  e f fects of chroni c  c l o z ap i ne on both 
the behaviora l  measures and the b lood and bra in 
structures , these rats rece ived 10 mg/kg inj ections o f  
c l o z ap ine one hour prior t o  operant sess ions and 
veh i c l e  inj ections one hour a fter the operant sess ions 
for 9 consecutive days . On day 10 the rats rece ived 1 0  
mg/kg o f  c l o z apine prior t o  the session a n d  were 
k i l l ed immed iately fol l owing the operant sess ion and 
t issue col l ect ion and assays were performed . 
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Group 3- CHRONIC PRESESS ION PI MOZIDE ( N  = 9 ) - To assess the 
behav ioral e f fects of chronic pimoz ide on both the 
behaviora l  measures and the blood and bra i n  
structures , these rats rece ived.1 mg/kg inj ections o f  
p imoz ide four hours prior t o  operant sess ions and 
vehicle inj ect ions one hour a fter the operant sess ions 
for 9 consecutive days . On day 10 the rats rece ived 1 
mg/kg of pimoz ide prior to the session and were ki l l ed 
immediately fol l owing the operant session and b lood 
a nd t i ssue assays were performed . 
Group 4 - POST/PRESESSION CLOZAPINE ( N  = 9 ) - In order to 
assess the mechani sms of tolerance whi ch a re contr­
ibut ing to the behaviora l ef fects of neuroleptic 
d rugs , these rats rece ived vehicle inj ect ions one hour 
prior to the operant sess ions and 10 mg/kg clozapine 
inj ections one hour a fter the operant sessions for 9 
consecutive days . On day 10 the inj ect ion cond itions 
were reversed w ith clo zapine given before and veh i c l e  
a fter operant sess ions . Thi s  condit ion continued for 
an additional 9 days . On day 19 the rats received 10 
mg/kg c l o z ap ine prior to the operant sess ion and were 
k i l l ed immed iately fol l owing the ope rant session and 
t ,issue col l ection and assays performed . 
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Group 5- POST/PRESESS ION PIMOZIDE ( N  = 9 ) - I n  order to 
assess any mechan isms of tolerance whi ch may 
contribute to the behav iora l  e f fects o f  neuroleptic 
d rugs these rats rece ived veh icle inj ections four 
hours prior to the operant sess ions and 10 mg/kg 
p imoz ide inj ect ions one hour a fter the operant 
sess ions for 9 consecutive days . On day 10 the 
inj ection conditions were reversed with pimoz ide giv�n 
before and vehicle a fter operant sess ions . Thi s  
cond ition cont inued f o r  an addit ional 9 days . O n  day 
19 the rats rece ived 10 mg/kg pimoz ide prior to the 
operant session and were kil l ed immediately fol l owing 
the operant session and tissue col l ect ion and assays 
performed . 
Group 6 - ACUTE CLOZAPINE ( N  = 8 )- To assess the a f fects o f  
acute c l o z apine for the HPLC assay , these rats 
�ece ived inj ections of the vehicle one hour prior to 
operant sessions and one hour a fter operant sess ions 
for 9 consecutive days . On the tenth day , an inj ection 
of c l o z ap ine ( 10 mgjkg )  was administered one hour 
prior to the operant session . Immediately fol l owing 
the operant session the rats were k i l l ed and t issue 
c o l l ection and assays were performed . 
Group 7 - ACUTE PIMOZIDE ( N  = 9 ) - To assess the e ffects o f  
a cute p imoz ide for the HPLC assay , these rats rece ived 
inj ections of the vehicle four hours prior to operant 
sess ions and one hour a fter operant sess ions for 9 
consecutive days . On the tenth day , they received an 
inj ect ion of p imoz ide (1 mgjkg ) four hours prior to 
the operant sess ion . Immed iately fol l owing the operant 
session the rats were ki l l ed and ti ssue c o l l ection and 
assays were performed . 
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HPLC Assays 
Rats were k i l l ed by decap itation on the appropriate 
day fol l owing the behaviora l test session . Trunk bl ood ( 5 - 6  
ml ) w a s  c o l l ected in tubes containing 0 . 0 5 ml sod ium 
heparin ( 10 , 0 0 0  un itsjml ) and the funnel conta ined 0 . 0 2 5  ml 
of the heparin stock . The b l ood tubes were m ixed by 
inversion and p laced on ice for 1-10 minutes . The b l ood was 
centri fuged for 7 minutes at 5' C at approximately 10 0 0  x 
G .  The plasma was aspirated and frozen on dry ice and 
stored at - 7 0 '  C unt i l  assayed . The bra ins were removed 
rapidly ,  and the frontal cortex and striatum were dissected 
accord ing to Glowinski and Iversen ( 19 6 6 ) . The bra in t i ssue 
was f ro z en on d ry ice and stored at -7 0 ·  C unti l  assayed . 
For the HPLC assays the tissues were homogeni z ed in a 
minimum o f  1 ml or 4 vols of phosphate buffer ( pH 3 . 0 ) . To 
the 1 ml of plasma or the homogenate , 5 0 0  ng o f  the 
internal standard ( loxapine ) , 0 . 5  ml carbonate and 5 ml of 
extracting solvent ( ethyl acetate , hexane , i soamyl a lcoho l , 
5 0 : 4 9 . 5 : 0 . 5 ) were added . Th is mixture was vortexed for 3 0  
sec , centri fuged a t  25 0 0  rpm for 1 0  min , and the organic 
l ayer was transferred to a 5 ml centri fuge t ube . I t  was 
then evaporated at 4 0 ·  C under nitrogen , d issolved i n  1 0 0  
�l o f  the mob i l e  phase and 25 �l was inj ected o n  the HPLC 
col umn . 
statistical Ana l ys i s  
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The n umbe r  o f  responses , number o f  re inforcers and th e 
total l ength o f  t ime in seconds the response l ever i s  h e l d  
down during each component were recorded f o r  each session . 
During the FI component , responses were b i nned by 1 5  second 
interva l s  to a l low computation of index of curvature ( IOC) 
to dete rmine any changes in the " FI sca l l op" patte rn o f  
respond ing . 
I ndex of curvat ure ( Fry et a l . 1 9 6 0 ) was calcul ated 
with the f o l l owing formula : 
where A 
(3 X D) - 2 X (A + B + C) 
4 X D 
Bin 1 ,  B Bin 1 + Bin 2, C Bin 1 + Bin 2 + Bin 
3 ,  and D = Bin 1 + Bin 2 + Bin 3 + Bin 4 .  with four b ins , 
the va lues o f  an IOC can range from - 0 . 2 5 to + 0 . 7 5 .  An IOC 
o f  - 0 . 2 5 indicates that a l l  of the responses occur during 
the f i rst 15 seconds of the GO-second f i xed interval ,  wh i l e  
a n  IOC o f  + 0 . 7 5 indicates that a l l  of the responses occur 
during the last 15 seconds of the GO-second f i xed interva l .  
An IOC o f  0 indicates that a l l  responses a re evenl y  
distributed over the four 1 5  second bins . 
Mean duration per response was ca lcul ated by d ividing 
the total durat ion per component ( total FI or FR duration 
in seconds ) by the number of responses per component .  
Responses per minute , re in force rs per sess ion and durat i on 
per response for both the FI and FR schedules and IOC for 
the FI s chedule were analyz ed s eparately us ing analys is of 
va riance ( ANOVA ) and Duncan ' s  post hoc tests where 
appropriate . concentrations of c l ozapine in the frontal 
cortex and striatum were analyzed using ANOVA and 
appropriate post hoc test s . Concent rations of p imoz ide 
could not be analyzed due to a l ack of sensit ivity of the 
HPLC a ssay with respect to pimoz ide . variables were 
analyzed by subj ect and by t ime where appropr iate . Each 
d rug was compared separately against the veh i c l e  
group . O n l y  stat i st ica l ly s ign i f icant resu lts ( p  < . 0 5 )  
were reported . 
For the POST/PRESESS ION groups , the f i rst day of pre­
sess ion drug administration ( day 1 0 )  was compared 
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separately to the f irst and tenth days of the CHRONIC group 
for that drug to determine whether tolerance developed 
during post-session d rug administration . I f  post-sess ion 
admini stration produced tolerance , the f irst presession 
drug day should not be d i f ferent from day 10 of the CHRONI C  
group . I f  post-sess ion administrat ion , however ,  d i d  not 
produce tolerance , the f irst presession drug day should not 
be d i f ferent from day 1 of the CHRONI C  group . 
3 0  
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Resu lts 
BASELINE DATA 
Ana l y s i s  o f  the mean basel ine data indicated that 
there were no s ign i ficant d i fferences between the groups 
for any of the dependent variables . 
CHRONI C  DOS ING DATA 
Fixed interval responses per minute 
F igure 1 shows the mean responses per minute for the 
FI s chedu l e  for the ten day chron ic dos ing regimen for the 
pre-cloz apine and pre-pimoz ide groups . 
C l o z apine . Cloz apine produced a s ign i f icant decrease 
i n  respond ing [ F  ( 1 , 1 4 )  = 7 . 4 7 8 , P = . 0 1 5] , a lthough there 
was a s ig n i f icant recovery in response rates as indicated­
by a s igni f icant drug x day interaction [ F  ( 9 , 1 2 6 )  = 3 . 1�2 , 
P = . 0 0 2 ] .  Post hoc tests reveal ed that on days 1 - 8  
c l o z apine suppressed responding below veh i c l e  rates , but by 
days 9 and 1 0  response rates had recovered to veh i c l e  
l evel s .  
Pimoz ide . Pimoz ide a l so produced a s ign i f icant 
suppress ion of respond ing [ F  ( 1 , 1 4 )  3 0 . 5 8 4 , p < . 0 0 1] and 
there was a s igni f icant decrease in respond ing across days 
for both the vehicle and the pimoz ide groups [ F  ( 9 , 1 2 6 )  
3 . 0 1 9 , P = . 0 0 3 ] . Response rates o n  days 7 - 9  were 
s ign i f icantly less than days 1 - 4  and day 1 0  wa s 
Figure 1 
Mean responses per minute for the F I  schedu l e  for the 
ten day chroni c  dos ing reg imen for anima l s  receiving 10 
mg/kg presess ion clozapine and 1 mg/kg presess ion p imo z ide . 
B represents basel ine response rates . 
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sign i ficantly less than days 1 ,  2 and 4 .  
Fixed interv a l  reinforcers 
Figure 2 shows the mean number of reinforcers earned 
for the FI schedule for the ten day chronic dosing regimen 
for the pre-cloz apine and pre-pimoz ide groups . 
C l o z apine . C l o z ap ine produced a sign i f icant decrease 
in the number of reinforcers earned [ F  ( 1 , 1 4 )  = 1 2 . 5 3 1 ,  P = 
. 0 0 3 ] a lthough , again , there was a s igni f icant recovery 
across days as ind icated by both a sign i f icant days e f fect 
[ F  ( 9 , 1 2 6 )  = 2 . 4 8 3 ,  P = . 0 1 2 ] and a sign i f icant drug x day 
interaction [ F  ( 9 , 1 2 6 )  = 2 . 6 3 4 , P . 0 08] . On days 1 - 4 , 
the c l o z ap ine group earned sign i f icantly fewer reinforcers 
than the vehicle group , but by day 5 - 1 0  the number o f  
reinforcers earned had returned t o  vehicle leve l s . withiA 
the c l o z apine group , the number o f  re i n forcers earned on , 
days 1 and 2 were s igni f icantly less than on days 5 - 1 0  and 
the number of reinforcers earned on days 3 and 4 were 
sign i f icantly less than on days 6 and 8 - 1 0 . 
Pimoz ide . Pimoz ide produced a sma l l ,  but sign i f i cant 
[ F  ( 1 , 1 4 )  = 9 . 4 9 2 , p = . 0 0 8 ] ,  decrease in the number o f  
rein forcers earned that rema ined stable across a l l  ten days 
o f  chronic dos ing . 
Index of curvature 
Figure 3 shows the mean index of curvature for the FI 
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Figure 2 
Mean reinforcers for the FI schedule for the ten day 
chroni c  dos ing regimen for animal s  rece iv ing 10 mg/kg 
presess ion clozap ine and 1 mg/kg presess ion p imoz ide . B 
represents base l ine response rates . 
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Figure 3 
Mean i ndex of curvature for the FI schedul e  for the 
ten day chronic dos ing reg imen for anima l s  receiving 1 0  
mg/kg presess ion cl ozapine a n d  1 mg/kg presess ion p imo z ide . 
B represents basel ine response rates . 
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schedu l e  for the ten day chron ic dos ing reg imen for the 
pre-clozapine and pre-p imoz ide groups . 
C l o z apine . To be included i n  the analyses for i ndex 
of curvature , a subj ect had to meet a minimum criterion of 
earni ng 10 f i xed interval reinforcers during the entire 
sess ion ; therefore , not a l l  subj ects were included in 
analyses for days 1 - 4 . Three subj ects were omitted from 
the analysis on days 1 and 2 and 1 subj ect was omitted on 
days 3 and 4 .  Due to d i f ferences in sample s i zes on each 
o f  these days , separate analyses of variance were performed 
on data for days 1-4 . Although the mean index of curvature 
was consi stently l ower for the clozapine group dur ing days 
1 - 4 , the only s igni f icant e f fect was on day 3 [ F  ( 1 , 1 2 )  = 
5 . 7 2 2 , P = . 0 3 2 ) . On days 5 - 1 0 , a l l  subj ects were inc luded 
in the repeated measures ( dependent samples ) analysis of -
variance , but there were no s igni f icant d i f ferences between 
the c l o z apine and vehicle groups . A problem with this 
analy s i s , however , is that the vehicle group was not stab l e  
across the t e n  days of cloz apine administrat ion , 
contributing to the l ack of s igni f icant d i f ferences between 
the two groups . 
Pimo z ide . Al l subj ects were included on a l l  days for 
the analys i s  of the p imoz ide data . Pimoz ide produced no 
s igni f i cant effect on index of curvature . 
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Fixed interval response duration 
Figure 4 shows the mean response durat i on for the FI 
schedule for the ten day chronic dosing regimen for the 
pre-cloz ap ine and pre-pimoz ide groups . 
C l o z apine . Due to l ack o f  respond ing by some clo zapine 
an ima l s  on days 1 - 4 , not a l l  an imal s  were included in 
theanalyses on these days and separate analyses o f  variance 
were performed on each o f  these days . Clozapine produced a 
sign i f icant increase in response duration on day 2 [ F  
( 1 , 1 1 )  = 5 . 2 4 8 ,  P = . 04 1] ,  day 3 [ F  ( 1 , 1 2 )  = 6 . 9 7 1 ,  p 
. 02 0] and day 4 [ F  ( 1 , 1 3 )  = 5 . 02 9 , P = . 0 4 1] ,  however 
duration recovered to vehicle leve ls by day 5 ,  as indicated 
by the l ack of sign i f icant e f fects for the dependent 
analys i s  of variance performed on days 5- 1 0 . 
Pimoz ide . A l l  subj ects were included in this analysis 
on a l l  days . Pimoz ide produced a sign i f icant increase in , 
response duration [ F  ( 1 , 1 4 )  = 1 5 . 5 1 1 , P = . 0 0 1] .  Response 
duration sign i f icant ly increased over the ten days , as 
i nd i cated by a sign i f icant days e f fect [ F  ( 9 , 1 2 6 )  = 2 . 5 9 8 , 
P = . 0 08] and a s ign i f icant drug x day interaction [ F  
( 9 , 1 2 6 )  = 2 . 0 7 5 ,  P = . 0 3 6] .  On days 3 and 5 - 1 0  p imoz ide 
response duration was s ign i f icantly l onger than vehicle 
l eve l s , and within the pimoz ide group , days 7-10 were 
s igni ficantly l onger than days 1 ,  2 and 4 and days 7 and 8 
were sign i f icantly l onger than day 3 .  
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Figure 4 
Mean response duration for the FI schedule for the ten 
day chronic dos ing regimen for animal s  receiving 10 mgjkg 
presess i on c l o z ap ine and 1 mgjkg presess ion p imoz ide . B 
represents base l i ne response rates . 
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Fixed rat io responses per minute 
Figure 5 shows the mean responses per minute for the 
FR schedule for the ten day chronic dosing regimen for the 
pre-clozapine and pre-pimo z ide groups . 
Clozapine . Clozapine produced a sign i f icant decrease 
in responding [ F  ( 1 , 1 4 )  = 9 . 5 9 5 ,  p . 0 07] ,  and there was a 
sign i f icant e f fect for days [ F  ( 9 , 1 2 6 )  = 2 . 3 4 9 ,  P = . 0 17 ] 
with response rates for both the clozapine and vehicle 
groups on day 3 be ing sign i f icantly l ess than on days 5 and 
7 - 1 0 . 
Pimoz ide . Pimoz ide produced a sign i f icant decrease in 
respond ing [ F  ( 1 , 1 4 )  = 2 3 . 4 6 2 ,  P < . 0 0 1] with a further 
decrease across days as indicated by a sign i f icant drug x 
day interaction [ F  ( 9 , 1 2 6 )  = 2 . 2 9 7 , P = . 0 2 0] .  On days 6 -
1 0 ,  response rates f o r  the pimoz ide group were 
sign i f i cantly less than on day 1 .  
Fixed rat io rein forcers 
Figure 6 shows the mean number of rein forcers earned 
for the FR schedule for the ten day chronic dos ing reg imen 
for the pre-c l o z apine and pre-p imoz ide groups . 
C l o z apine . Clozapine produced a sign i f icant decrease 
in number o f  reinforcers earned [ F  ( 1 , 1 4 )  = 9 . 6 0 0 ,  P 
. 0 07] and there was a signi f icant increase in number o f  
reinforcers earned across days for both the vehicle and 
c l o z ap ine groups [ F  ( 9 , 1 2 6 )  2 . 3 2 2 ,  p = . 0 18] . The number o f  
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Figure 5 
Mean responses per minute for the FR schedul e  for the 
ten day chronic dos ing regimen for anima l s  receiv ing 1 0  
mgjkg preses sion c l o z ap ine a n d  1 mgjkg presession pimoz ide . 
B represents basel ine response rates . 
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Figure 6 
Mean reinforcers for the FR schedule for the ten day 
chron ic dos i ng regimen for animal s  rece iv ing 10 mg/kg 
presess i on c l o z ap ine and 1 mg/kg presess i on p imoz ide . B 
represents base l ine response rates . 
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re inforcers earned on days 5 - 1 0  were s igni ficantly greate r 
than on days 1 ,  3 and 4 and the number earned on days 7 , 9 
and 1 0  signi ficantly greater than on day 2 .  
Pimoz ide . Pimoz ide a l so produced a sign i f icant 
decrease in number of rein forcers earned [ F  ( 1 , 1 4 )  = 
2 3 . 0 2 6 ,  P < . 0 0 1] ,  however , the number of rein forcers 
cont inued to decrease across days for the pimoz ide anima l s  
a s  ind i cated b y  a signi ficant drug x day interact ion [ F  
( 9 , 1 2 6 )  = 2 . 2 3 1 ,  P = . 0 2 3] .  For the p imo z ide group the 
number of re inforcers earned on days 6 - 1 0  were 
s ign i f i cantly less than on day 1 .  
Fixed ratio response duration 
Figure 7 shows the mean response durat ion for the FR 
schedu l e  for the ten day chron ic dos ing regimen for the 
pre-clozapine and pre-pimoz ide groups . 
C l o z apine . Aga in , due to l ack of respond ing by some 
c l o z ap ine anima l s ,  not a l l  subj ects were included on days 
1-4 and separate analyses were performed on each of these 
days . C l o z ap ine produced sign i f icant increases in response 
durat ion only on day 3 [ F  ( 1 , 1 2 )  = 1 0 . 6 5 8 , P = . 0 0 6] and 
day 4 [ F  ( 1 , 1 3 )  = 6 . 1 4 5 ,  P = . 0 2 6] .  The increase in 
response durat ion on day 2 fa i led to reach sign i f icance 
because of the sma l l  sample s i z e  ( N  = 5 )  and l arge 
variab i l ity in the data for the clozapine anima l s .  A 
dependent samples ana lysis of variance performed on a l l  
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Figure 7 
Mean response durat i on for the FR schedule for the ten 
day chronic dosing regimen for animal s  receiving 10 mg/kg 
presession cl ozapine and 1 mg/kg presess ion pimoz ide . B 
represents basel ine response rate s .  
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subj ects on days 5 - 1 0  indicated that mean response duration 
for the c l oz apine anima l s  had returned to vehicle level s .  
Pimoz ide . Pimoz ide s ignificantly increased response 
dura t ion [ F  ( 1 , 1 4 )  = 1 9 . 7 5 9 , P < . 0 0 1 ] . A sign i ficant days 
e ffect [ F  ( 2 , 1 2 6 )  = 3 . 0 2 5 , p . 0 02 ] and a sign i fi cant drug 
x day interaction [ F  ( 2 , 1 2 6 )  2 . 8 3 1 ,  p = . 0 0 4 ] indicated 
that there was a cont inued increase in durat ion across days 
for the p imoz ide group , with the mean response duration for 
p imoz ide being sign i f icantly longer than for vehicle on 
days 3 a nd 5 - 1 0 .  For the pimoz ide group , response durat ion 
on days 9 and 1 0  were sign i f icantly l onger than on days I ­
S .  
BEHAVIORAL TOLERANCE DATA 
Analysis o f  variance was used to compare the ten days 
of pre-sess ion drug inj ections ( days 1 0 - 1 9 ) with the 
corresponding veh icle data to determine if similar e f fects 
were obtained for the behavioral tolerance groups ( POST/PRE 
CZP and POST/PRE PMZ ) as for the chron ic dosing groups . I n  
add i t i on , the f irst day o f  presession drug administrat ion 
f o l l owing n ine days o f  post-sess i on dos ing ( POST/ PRE day 
1 0 )  was compared separately to the first and tenth days of 
CHRONI C  drug administration for the appropriate drug . 
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Fixed interval responses per minute 
Figure 8 shows the mean number of responses per minute 
for the FI schedule for the behavioral tolerance study . 
Panel A shows the data for the vehicle animal s  ( days 1-19 ) 
and the POST/ PRE c l o z apine animals ( post-session inj ect ions 
on days 1 - 9 , presession inj ect ions on days 1 0 - 19 ) . The data 
for the CHRONI C  pre-clozapine anima l s  ( days 1 - 1 0 )  are shown 
for compari son . Panel B shows the data for the veh icle 
an imal s  ( days 1 - 1 9 ) and the POST/ PRE pimoz ide anima l s  
( post-session inj ect ions o n  days 1 - 9 , presession inj ecti ons 
on days 1 0 - 19 ) . The data for the CHRONIC pre-pimoz ide 
anima l s  ( days 1 - 1 0 ) a re shown for comparison . 
C l o z apine . Pre-session c l o z apine inj ect ions ( days 1 0 -
1 9 )  sign i f i cantl y  decreased response rates [ F  ( 1 , 1 4 )  = 
5 . 7 3 2 , P = . 0 2 9 ] .  Whi l e  response rates for the cl ozapine 
group did not recover to basel ine l eve l s  within the ten 
days o f  pre-session inj ect ions [F ( 9 , 1 2 6 )  = 2 . 2 8 4 , P = 
. 0 2 0 ] , there was a s igni fi cant drug x days interaction [ F  
( 9 , 1 2 6 )  = 2 . 17 4 , P = . 0 2 7 ]  indicat ing that within the 
POST/PRE cl ozapine group , respond ing on days 1 4 - 17 and 19 
was s ign i f icant ly greater than on day 1 0 ,  responding on 
days 1 2 - 19 was sign i ficantly greater than on day 1 1 ,  and 
respond ing on day 14 was s ign i f icantly greater than on days 
12 and 1 3 . Pl anned comparisons showed that the f irst day o f  
presession drugging f o r  the POST/ PRE c l o z ap ine group 
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Figure 8 
Mean responses per minute for the FI schedul e  for the 
behav ioral tolerance study . Panel A shows the data for the 
veh i c l e  anima l s  ( days 1 - 1 9 ) and the POST/ PRE cl ozapine 
a nimal s  ( post-sess i on inj ections on days 1 - 9 , preses sion 
inj ect i ons on days 1 0 - 19 ) . The data for the CHRONIC pre­
c l o z ap ine anima l s  ( days 1 - 1 0 )  are shown for comparison . 
Panel B shows the data for the veh icle animal s  ( days 1 - 1 9 ) 
and the POST/PRE p imoz ide an imal s  ( post-session inj ections 
on days 1 - 9 , presess ion inj ections on days 1 0 - 1 9 ) . The data 
for the CHRONI C  pre-pimoz ide an ima l s  ( days 1 - 1 0 )  are shown_ 
for compari son . B represents base l ine response rates . 
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( POST/PRE day 1 0 )  was not s ignificantly d i fferent from 
e i ther day 1 or day 10 of the pre-clozapine group . 
Pimoz ide . Pre-session pimoz ide ( days 1 0 - 1 9 )  
sign i f icantly decreased response rates [ F  ( 1 , 1 4 )  = 2 3 . 0 0 8 , 
P < . 0 0 1 ]  and there was a s ign i f icant decrease in 
responding across days for both the vehicle and pimo z ide 
groups [ F  ( 9 , 12 6 )  = 2 . 3 3 1 ,  P = . 0 1 8 ] . Response rates on 
days 1 7 - 19 were sign i f icantly l ess than response rates on 
days 12 and 1 3 . Pl anned compari sons showed that the f irst 
day of presession pimoz ide administrat ion for the POST/ PRE 
p imoz ide group ( day 1 0 )  a l so was not s igni f icantly 
d i fferent from days 1 or 10 o f  the CHRONI C  pre-session 
pimo z ide group . 
Fixed interval rein forcers 
Figure 9 shows the mean number of reinforcers earned 
for the FI schedul e  for the behavi ora l tolerance study . 
Panel A shows the data for the vehicle anima l s  ( days 1 - 1 9 )  
and the POST/PRE c l o z apine animal s  ( post-session inj ecti ons 
on days 1 - 9 , presess ion inj ections on days 1 0 - 1 9 ) . The data 
for the CHRONI C  pre-clozapine an ima l s  ( days 1 - 1 0 )  are shown 
for compari son . Panel B shows the data for the vehicle 
anima l s  ( days 1 - 1 9 ) and the POST/ PRE p imoz ide anima l s  
( post-sess i on inj ections o n  days 1-9 , presess ion inj ecti ons 
on days 1 0 - 19 ) . The data for the CHRONIC pre-p imoz ide 
anima l s  ( days 1 - 1 0 )  are shown for compari son . 
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Figure 9 
Mean re inforcers for the FI schedule for the 
behaviora l  tolerance study . Panel A shows the data for the 
veh i c l e  animal s  ( days 1 - 1 9 ) and the POST/PRE c l o z ap ine 
an imal s  ( post-session inj ections on days 1 - 9 , presession 
inj ect i ons on days 1 0 - 19 ) . The data for the CHRONIC pre­
c l o z apine anima l s  ( days 1 - 1 0 )  are shown for comparison . 
Pane l B shows the data for the vehicle animal s  ( days 1 - 1 9 ) 
and the POST/PRE pimoz ide animal s  ( post-session inj ect ions 
on days 1 - 9 , presess ion inj ections on days 1 0 - 1 9 ) . The data 
for the CHRONIC pre-pimoz ide anima l s  ( days 1 - 1 0 )  are shown 
for comparison . B represents basel ine response rates . 
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C l o z apine . Pre-session inj ections o f  c l o z ap ine ( day 
1 0 - 1 9 ) produced a sign i f i cant decrease in number o f  
reinforcers earned [ F  ( 1 , 1 4 )  = 2 1 . 07 6 ,  P < . 0 0 1 ) , a lthough 
there was a s ign i f i cant recovery across days as ind icated 
by a sign i ficant days e f fect [ F  ( 9 , 1 2 6 )  = 5 . 4 7 5 , P < . 0 0 1 )  
and a sign i f icant drug x day interacti on [ F  ( 9 , 12 6 )  = 
4 . 7 8 9 ,  P < . 00 1 ) . On days 1 0  and 1 1  the c l oz apine group 
earned fewer rein forcers than the veh icle group , but by day 
12 the number of reinforcers earned had returned to vehic l e  
l eve l s . For the c l oz apine anima l s , the number o f  
reinforcers earned o n  days 1 0  and 1 1  was s ign i f icantly 
l essthan on days 1 3 - 1 9 . Pl anned compari sons show that day 
10 for the POST/PRE clozapine an imal s  was s ign i fi cantly 
less than day 10 o f  the CHRONIC c l o z apine group , but not 
day 1 .  
Pimoz ide . Pre-session pimoz ide inj ections ( days 1 0 - 1 9) 
produced a sma l l  but s igni f icant decrease in the number o f  
reinforcers earned [ F  ( 1 , 1 4 )  = 1 2 . 8 6 0 ,  P = . 0 0 3 ) . Pl anned 
compari sons ind icated that POST/ PRE day 10 was not 
s ign i f icantly d i f ferent from CHRONI C  pimoz ide days 1 or 1 0 . 
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Index o f  curvature 
Figure 10 shows the mean index of curvature for the FI 
schedule for the behavioral tol erance study . Panel A shows 
the data for the vehicle an ima l s  ( days 1 - 1 9 ) and the 
POST/ PRE c l o z apine an ima l s  ( post-session inj ect ions on days 
59 
Figure 1 0  
Mean index o f  curvature for the F I  schedule for the 
behav ioral tol erance study . Panel A shows the data for the 
veh i c l e  anima l s  ( days 1 - 1 9 ) and the POST/ PRE c l oz apine 
anima l s  ( post-sess i on inj ections on days 1 - 9 , presess ion 
inj ections on days 1 0 - 19 ) . The data for the CHRONIC pre­
c l o z apine anima l s  ( days 1 - 1 0 )  are shown for comparison . 
Panel B shows the data for the vehicle animals ( days 1 - 1 9 ) 
and the POST/PRE p imoz ide anima l s  ( post-session inj ections 
on days 1 - 9 , presess ion inj ections on days 1 0 - 1 9 ) . The data 
for the CHRONI C  pre-pimoz ide animal s  ( days 1 - 1 0 )  a re show� 
for comparison . B represents basel ine response rates . 
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1 - 9 , presess ion inj ections on days 1 0 - 1 9 ) . The data for the 
CHRONIC pre-cl o z apine anima l s  ( days 1 - 1 0 )  are shown for 
comparison . Panel B shows the data for the vehicle an imal s  
( days 1 - 1 9 ) a n d  the POST/ PRE pimoz ide animal s  ( post-session 
inj ections on days 1 - 9 , presession inj ections on days 1 0 -
1 9 ) . The data for the CHRONIC pre-pimoz ide anima l s  ( days 1 -
1 0 )  are shown for comparison . 
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C l o z apine . To be included in the analyses for index of 
curvature , a subj ect had to meet a minimum criterion of 
earning 10 f ixed interval reinforcers during the ent ire 
sess i on ; therefore only five c l ozapine an imal s  were 
included in the analys i s  for day 1 0 . , but a l l  subj ects were 
included in the ANOVA for days 1 1- 1 9 . Pre-session c l o z apine 
inj ect ions on day 10 produced a s igni fi cant decrease in 
i ndex o f  curvature (F ( 1 , 1 0 )  = 5 . 3 3 3 , P = . 0 4 1 ]  when 
compared to day 1 0  of the vehicle group , as did the pre­
sess ion c l o z apine inj ections for days 1 1 - 1 9  [ F  ( 1 , 1 4 )  = 
7 . 07 7 , P = . 0 1 7 ] . Pl anned comparisons indicated that day 1 0  
o f  the POST/ PRE cloz apine group was not s igni f i cantly 
d i f ferent from day 1 or day 10 o f  the CHRONIC c l o z apine 
group . 
Pimoz ide . Pre-sess ion p imoz ide inj ections ( days 1 0 - 1 9 ) 
had no sign i f i cant e f fect on index o f  curvature . 
Fixed interva l response duration 
Figure 1 1  shows the mean response durat ion for the FI 
schedu l e  for the behavioral tolerance study . Panel A shows 
the data for the vehicle animal s  ( days 1 - 1 9 ) and the 
POST/PRE c l o z apine anima l s  ( post-session inj ections on days 
1 - 9 , presess i on inj ect i ons on days 1 0 - 19 ) . The data for the 
CHRONI C  pre-clo z ap ine anima l s  ( days 1 - 1 0 ) are shown for 
comparison . Panel B shows the data for the vehicle an ima l s  
( days 1 - 1 9 ) and the POST/PRE p imoz ide anima l s  ( post-session 
inj ect i ons on days 1 - 9 , presession inj ections on days 1 0 -
1 9 ) . The data f o r  the CHRONIC pre-pimoz ide animal s  ( days 1 -
1 0 )  are shown f o r  compari son . 
C l o z apine . Pre-session c l o z apine inj ect ions had no 
s igni f icant e ffect on fixed interval mean response 
durat i on . 
Pimo z ide . Pre-session p imoz ide ( days 1 0 - 1 9 ) produced a 
sign i ficant increase in response durat i on [ F  ( 1 , 1 4 )  = 
1 9 . 6 4 2 ,  P < . 0 0 1 ]  and there was a sign i fi cant increase ove r  
t ime for the pimoz ide group as indicated b y  a sign i ficant 
days e f fect [ F  ( 9 , 1 2 6 )  = 6 . 1 6 7 , P < . 0 0 1 ]  and a sign i f icant 
drug x day interact ion [ F  ( 9 , 1 2 6 )  5 . 7 2 2 ,  p < . 0 0 1 ] . 
Durat ion for the pimoz ide group was s ign i f icantly greater 
than for vehicle on a l l  ten days o f  pre-session drug 
administrat ion ; however ,  within the pimoz ide group , days 
1 4 - 1 9  were sign i f icant ly greater than days 1 0 ,  12 and 1 3 , 
days 1 5  and 1 7 - 1 9  were s ign i f icantly greater than days 1 1  
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Figure 1 1  
Mean response durat i on for the F I  schedul e  for the 
behav ioral tol erance study . Panel A shows the data for the 
vehicle anima l s  ( days 1 - 1 9 ) and the POST/PRE c l o z apine 
anima l s  ( post-session inj ections on days 1 - 9 , presession 
inj ect ions on days 1 0 - 19 ) . The data for the CHRONIC pre­
c l o z ap ine anima l s  ( days 1 - 1 0 )  are shown for comparison . 
Panel B shows the data for the vehicle animal s  ( days 1 - 1 9 ) 
and the POST/ PRE pimoz ide anima l s  ( post-session inj ections 
on days 1 - 9 , presession inj ections on days 1 0 - 1 9 ) . The data 
for the CHRONI C  pre-pimoz ide anima l s  ( days 1 - 1 0 )  are shown 
for comparison . B represents basel ine response rates . 
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and 1 6  and days 1 5  and 17 were sign i f icantly greater than 
day 1 4 , indicat ing an i ncrease in FI response duration over 
the ten days of presess ion drug admini strat i on . Planned 
compari sons indicated that POST/PRE day 10 was 
s igni f icantly less than day 10 of the CHRONI C  pimoz ide 
group but was not s ign i f icantly d i f ferent from day 1 .  
F ixed rat i o  responses per minute 
Figure 12 shows the mean number of responses per 
minute for the FR schedule for the behavioral tolerance 
study . Panel A shows the data for the vehicle anima l s  ( days 
1 - 1 9 )  and the POST/PRE cloz apine anima l s  ( post-session 
inj ections on days 1 - 9 , presession inj ect ions on days 1 0 -
1 9 ) . The data for the CHRONI C  pre-clozap ine anima l s  ( days 
1 - 1 0 )  are shown for compari son . Panel B shows the data for_ 
the veh i c l e  a n ima l s  ( days 1 - 1 9 ) and the POST/ PRE pimoz ide 
anima l s  ( post-session inj ections on days 1 - 9 , presess ion 
inj ections on days 1 0 - 1 9 ) . The data for the CHRONIC pre­
p imoz ide a n ima ls ( days 1 - 1 0 )  are shown for comparison . 
C l o z apine . Pre-session cl ozapine inj ect ions on days 
1 0- 1 9  produced a s ign i f icant decrease in response rate [ F  
( 1 , 1 4 )  = 8 . 08 2 , P = . 0 1 2 ] . Planned compari sons indicated 
that POST/PRE day 1 0  was not sign i f icantly d i f ferent from 
day 1 or day 1 0  of the CHRONIC presess ion c l o z ap ine group . 
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Pimoz ide . Pre-sess ion inj ect ions ( days 1 0 - 1 9 )  produced 
a s igni f i cant decrease in response rate [ F  ( 1 , 1 4 )  = 2 2 . 5 1 9 , 
F igure 1 2  
Mean responses per minute for the F R  schedul e  for the 
behavi oral tolerance study . Panel A shows the data for the 
vehicle anima l s  ( days 1 - 1 9 )  and the POST/PRE cl ozapine 
a n imal s  ( post-sess ion inj ecti ons on days 1 - 9 , presession 
inj ecti ons on days 1 0 - 19 ) . The data for the CHRONI C  pre­
c l o z ap ine an imal s  ( days 1 - 1 0 )  are shown for comparison . 
Panel B shows the data for the vehicle animal s  ( days 1 - 1 9 ) 
and the POST/PRE pimoz ide animal s  ( post-sess ion inj ect ions 
on days 1 - 9 , presess ion inj ections on days 1 0 - 19 ) . The data 
for the CHRONI C  pre-p imo z ide anima l s  ( days 1 - 1 0 )  are show� 
for compari son . B represents basel ine response rates . 
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p < . 0 0 1 ] . Response rates for the pimo z ide group continued 
to decl ine over the ten days as indicated by a sign i ficant 
days e f fect [ F  ( 9 , 1 2 6 )  = 4 . 4 0 2 , P < . 00 1 ]  and a sign i f icant 
drug x day interaction [ F  ( 9 , 1 2 6 )  2 . 1 5 0 , p = . 02 9 ]  that 
revealed that days 1 5 - 1 9  were s ignificantly less than days 
1 0 ,  12 a nd 1 3 . Planned comparisons indicated that POST/PRE 
day 1 0  was signi f i cantly greater than day 1 0  for the 
CHRONI C  p imoz ide group but not day 1 .  
Fixed rat io rein forcers 
F igure 13 shows the mean number of reinforcers earned 
for the FR schedule for the behavioral tol erance study . 
Panel A shows the data for the veh i c l e  an imal s  ( days 1 - 1 9 ) 
and the POST/ PRE c l oz apine animal s  ( post-session inj ections 
on days 1 - 9 , presess ion inj ecti ons on days 1 0 - 1 9 ) . The da�a 
for the CHRONI C  pre-c l o z apine animal s  ( days 1 - 1 0 )  are shown 
for compari son . Panel B shows the data for the vehicle 
anima l s  ( days 1 - 1 9 ) and the POST/PRE p imoz ide anima l s  
( post-sess i on inj ections o n  days 1 - 9 , presession inj ections 
on days 1 0 - 19 ) . The data for the CHRONI C  pre-pimoz ide 
anima l s  ( days 1 - 1 0 )  are shown for comparison . 
C l o z apine . Pre-session c l o z apine inj ections ( days 10-
1 9 )  produced a sign i f icant decrease in the number o f  
reinforcers earned [ F  ( 1 , 1 4 )  = 6 . 8 4 2 , P = . 0 1 9 ] . Whi l e  the 
c l oz apine group did not recover to vehic l e  l evel s  during 
the ten days o f  pre-session inj ections , a sign i f icant drug 
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Figure 13 
Mean reinforcers for the FR schedul e  for the 
behavioral tolerance study . Panel A shows the data for the 
veh icle anima l s  ( days 1 - 1 9 )  and the POST/PRE c l o z apine 
anima l s  ( post-session inj ect ions on days 1-9 , presession 
inj ections on days 1 0 - 19 ) . The data for the CHRONIC pre­
c l o z apine animal s  ( days 1 - 1 0 )  are shown for comparison . 
Panel B shows the data for the vehicle anima l s  ( days 1 - 19 ) 
and the POST/ PRE p imoz ide anima l s  ( post-sess ion inj ections 
on days 1 - 9 , presession inj ections on days 1 0 - 1 9 ) . The data 
for the CHRONI C  pre-pimoz ide anima l s  ( days 1 - 1 0 )  are shown 
for comparison . B represents basel ine response rates . 

x day interaction [ F  ( 9 , 1 2 6 )  = 2 . 12 7 , P = . 0 3 1 ]  ind icated a 
sign i ficant increase across days for the c l oz ap ine group , 
with days 1 4 - 1 6  be ing s igni f icantly greater than day 1 0  and 
days 1 7 - 1 9  being s ign i ficant ly greater than day 1 1 .  Pl anned 
comparisons ind icated that POST/PRE day 10 was not 
s ign i fi cantly d i f ferent from day 1 or day 10 of the CHRONI C  
presess ion c l oz apine group . 
Pimoz ide . Pre-sess i on inj ections produced a decrease 
in number o f  reinforcers earned [ F  ( 1 , 1 4 )  = 2 0 . 7 2 0 ,  P < 
. 0 0 1 ) . Planned compari sons indicated that POST/PRE day 1 0  
w a s  sign i f icantly greater than day 1 0  o f  the CHRONIC 
p imoz i de group . 
Fixed rat i o  response durat i on 
Figure 1 4  shows the mean response durat ion for a l l  1 9  
days f o r  the F R  schedule f o r  the behavioral tolerance 
study . Panel A shows the data for the vehicle animal s  ( days 
1 - 1 9 ) and the POST/PRE c l o z apine anima l s  ( post-session 
inj ecti ons on days 1 - 9 , presession inj ect i ons on days 1 0 -
1 9 ) . The data f o r  the CHRONIC pre-c l oz apine anima l s  ( days 
1 - 1 0 )  a re shown for compari son . Panel B shows the data for 
the veh i c l e  anima l s  ( days 1 - 1 9 )  and the POST/ PRE pimoz ide 
anima l s  ( post-session inj ections on days 1 - 9 , presession 
inj ecti ons on days 1 0 - 19 ) . The data for the CHRONI C  pre­
pimo z ide animal s  ( days 1 - 1 0 )  are shown for comparison . 
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Figure 1 4  
Mean response durat ion for the FR schedu l e  for the 
behavioral tolerance study . Panel A shows the data for the 
vehicle anima l s  ( days 1 - 1 9 ) and the POST/PRE c l o z apine 
anima l s  ( post-sess ion inj ecti ons on days 1 - 9 , presess i on 
inj ections on days 1 0 - 19 ) . The data for the CHRONI C  pre­
c l o z ap ine anima l s  ( days 1 - 1 0 )  are shown for comparison . 
Panel B shows the data for the vehicle anima l s  ( days 1 - 1 9 ) 
and the POST/ PRE pimoz ide animal s  ( post-session inj ect ions 
on days 1 - 9 , presession inj ect ions on days 1 0 - 19 ) . The data 
for the CHRONI C  pre-pimoz ide anima l s  ( days 1 - 1 0 )  are show� 
for comparison . B represents basel ine response rates . 
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C l o z apine . Presess ion clozapine inj ect ions ( days 1 0 -
1 9 ) produced a sign i f icant drug x day interaction [ F  
( 9 , 1 2 6 )  = 2 . 3 59 , P = . 0 1 6] ,  indicat ing that response 
duration for the c l o z apine group was s igni f icantly lower 
than for veh i c l e  on days 10 and 1 1 ,  but recovered to 
veh i c l e  l evel s  by day 1 2 . within the c l o z apine group , 
response durat i on on days 1 2 - 19 was signi ficantly l onger 
than on days 1 2 - 19 . Planned comparisons indicated that 
POST/ PRE day 10 was not s ignificantly d i f ferent from day 1 
or day 1 0  o f  the CHRONIC cloz apine group . 
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Pimo z ide . Presession pimoz ide inj ections ( days 1 0 - 1 9 ) 
produced a sign i ficant increase in response durat ion [ F  
( 1 , 14 )  = 2 3 . 7 4 8 ,  P < . 0 0 1] Across days , the pimoz ide group 
continued to show increases in response durat ion as 
ind icated by a sign i f icant days e f f�ct [F ( 9 , 1 2 6 )  = 7 . 7 5 6 , 
P < . 00 1 ]  and a sign i f icant drug x day interaction [ F  
( 9 , 1 2 6 )  = 6 . 3 7 2 , P < . 0 0 1] that ind icated that within the 
p imoz ide group , days 15 and 1 7 - 1 9  were signi ficantly 
greater than days 1 0 - 1 4 . Planned comparisons indicated that 
POST/ PRE day 10 was s igni ficantly less than day 1 0  of the 
CHRONIC pre-p imoz ide group but not day 1 .  
HPLC DATA 
HPLC data i s  presented only for the cloz apine and 
vehicle control anima l s .  Data for pimoz ide are not 
currently ava i l able due to sens itivity l imitations o f  the 
HPLC procedure . 
Bl ood pl asma 
Tabl e  1 shows the mean nanograms of c l oz ap ine per 
m i l l i l iter of b l ood plasma for the acute ( s ingle dose ) , 
chronic ( 1 0 days ) , and POST/PRE ( 19 days ) groups . The 
standard error o f  the mean ( SEM) i s  in parenthes i s . There 
were no sign i f icant d i f ferences among the three c l o z apine 
groups . 
cortex 
Tab l e  2 shows the mean micrograms o f  c l o z ap ine per 
gram o f  tissue for the acute ( s ingl e  dose) , chron ic ( 1 0 
days ) , and POST/PRE ( 19 days ) groups . The standard error o f  
t h e  mean ( SEM ) i s  in parenthesis . There were no sign i f icant 
, 
d i f ferences among the three c l oz apine groups . 
striatum 
Table 3 shows the mean micrograms o f  c l oz apine per 
gram of t i ssue for the acute ( s ingle dose ) , chronic ( 1 0  
days ) , and POST/PRE ( 1 9 days)  groups . The standard error o f  
t h e  mean ( SEM) i s  in parenthes is . There were no sign i f icant 
d i f ferences among the three clozapine groups . 
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MEAN NG/ML 
SEM 
ACUTE 
( N  = 6 )  
4 17 . 1 7 
( 9 0 . 8 5 )  
Table 1 
CHRONIC 
(N = 9 )  
2 2 2 . 4 4 
( 3 0 . 4 2 )  
POST/PRE 
( N  = 8 )  
3 19 . 8 8 
( 4 6 . 2 2 )  
7 6  
MEAN p.G/G 
SEM 
ACUTE 
( N  = 6 )  
8 . 8 8 
( 2 . 8 6 )  
Tabl e  2 
CHRONI C  
( N  = 9 )  
5 . 9 8 
( o . 9 i ) 
POST/ PRE 
( N  = 8 )  
9 . 69 
( 1 .  6 2 ) 
7 7  
MEAN /.4G/G 
SEM 
ACUTE 
(N = 5 )  
1 1 .  3 8  
( 1 . 2 3 )  
Table 3 
CHRONIC 
( N  = 9 )  
POST/ PRE 
( N  = 8 )  
8 . 8 1 
( 1 . 8 4 )  
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Discussion 
As expected , acute administration of c l o z ap ine and 
p imoz ide disrupted operant responding on both FI and FR 
schedules . Chronic drug administrat ion , however , yielded 
d i f f erent i a l  results for the two drugs . In genera l , chroni c  
administrat ion of clozap ine resulted in tol erance t o  the 
drug ' s  rate reducing e ffects , whereas pimoz ide-treated rats 
exhibited " behaviora l sensitivity" to the drug ' s  e f fects . 
C l o z apine 
The e f fects of chroni c  c l oz apine on the response and 
reinforcement rate during f i xed interval were in agreement 
with prev ious studies uti l i z ing interval schedules ( see 
Kaemp f & Porter , 1 9 8 7 ; V i l l anueva & Porter , 1 9 8 7 a ,  b ) . 
C l o z ap ine produced an initial disruption of operant 
response rates and response duration , with the subsequent 
devel opment of tolerance to the rate disrupt ing e f fects 
with i n  the ten days of chronic drug administration . 
However , c l o zapine a l so disrupted the pattern o f  FI 
responding ( i . e . , IOC ) . The IOC measure for c l o z apine was 
consistently l ower than veh icle rates on a l l  except one of 
the ten days , a lthough the ana lysis of the chronic 
presession c l o z apine group ind icated that IOC was 
sign i f icantly suppressed only on day 3 .  The fa i l ure to 
obta in sign i f icance in this ana lysis was probably due to 
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the unusua l l y  h igh degree o f  variab i l ity in the vehicle 
group on this measure . Presess ion cloz apine inj ect ions 
produced a sign i f icant decrease in the IOC for the POST/PRE 
c l o z ap ine group on days 1 0 - 1 9  of the behavioral tolerance 
study , provid ing further evidence of clozapine ' s  IOC 
d is rupting e f fects . A problem with the IOC measure was the 
samp l e  s i z e  of the c l ozapine group on days 1-4 . Clozapine 
frequentl y  suppressed responding completely over the first 
few days o f  presession drug administration , there fore , 
anima l s  not responding had no pattern of response and thus 
IOC coul d  not be ca lculated for these anima l s . Likewise , 
the IOC for animal s  respond ing at very l ow rates did not 
rel i ably describe the response pattern . Due to these 
factors , anima l s  not earning at l east 10 reinforcers dur ing 
the F I  schedule component were not included in the ana lysj s 
on that day , thus decreas ing the sample s i z e  of the 
c l o z apine group and perhaps contributing to the l ack of 
sign i f i cant d i f ferences on days 1-4 . 
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A previous study by Vi l lanueva & Porter ( 19 8 7 ) 
emp l oy ing a behav ioral tolerance paradigm with neurol ept ics 
produced equ ivocal results with respect to the mechanism of 
tolerance to c l ozapine due to the complexity of the 
multiple schedule . The results indicated that the 
mechani sms of tolerance to clozapine ( di spos it ional or 
funct ional )  depended on the density of the re in forcement 
schedule . The results from the present study are somewhat 
cl earer in that a l l  of the dependent variables suggested 
that the development of tolerance is due primarily to 
funct ional mechanisms . The absence of d i fferences between 
the f i rst day of presess ion drug administration for the 
POST/PRE c l o z apine group and the first day of presession 
drug admini stration for the CHRONIC clozapine group 
suggests that the nine days of post-session drug 
administration had l ittle or no e ffect on the subsequent 
presession c l oz ap ine administration . The only e ffect of 
post-session c l o z apine admini stration was to accel erate 
s l ightl y  the devel opment of tolerance on the FI 
rein forcement measure . 
I n  contrast to the CHRONI C  presess ion phase of drug 
admin istrat ion , the IOC measure for the POST/PRE clozapine 
group for the presess ion phase of drug administration ( dqys 
1 0 - 19 ) was sign i f icantly suppressed . However ,  no s ign o f  
recovery w a s  evident for the IOC measure over the ten days 
of chronic drug admini strat ion . Th is f inding d i f fers from 
Kaempf and Porter ' s  study ( 19 8 7 ) that found that tolerance 
devel ops to the IOC disruption produced by chronic 
c l o z apine . The results o f  the present study suggest that 
for the FI schedul e ,  tolerance devel ops to the rate 
disrupt ing e f fects of the drug , but that a " t iming" deficit 
may pers ist throughout the drug administration period . Th is 
deficit is not proposed to be a motivat iona l deficit 
because the FI response rates and re inforcement rates 
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recovered to vehicle levels . The d iscrepancy between the 
present study and Kaempf and Porter ' s  ( 19 8 7 )  study may be 
due to d i f ferences in tra in ing and re inforcement schedules . 
The Kaemp f and Porter ( 1 9 8 7 ) study did not use a multiple 
schedul e ,  but a s impl e  FI 6 0-second schedule . The 
introduct ion of the FR- 3 0 schedul e  in the present study may 
have a f fected the FI pattern of responding . 
The e f fects of c l ozapine on FR respond ing were not 
ident ical to its e ffects on FI responding in that the 
chroni c  drug administration revea led a d i fferent ial 
devel opment o f  tolerance on the two schedules . The FI 
response rates recovered to vehicle leve l s  within the ten 
days o f  drug administrat ion , but the FR response rates did 
not . The POST/ PRE c l o z apine group a l so d id not deve l op 
tolerance on the FR response and re in forcement measures , 
and the n ine days o f  post-sess ion drug administration aga in 
had l ittle e f fect on the subsequent ten days o f  presession 
drug administrat ion . To lerance did deve lop , however , on the 
FR response duration measure . A study by Leander ( 19 8 3 )  
using p igeons to compare the e ffects o f  c l o z apine on FI and 
FR schedules found that clozapine produced a s imi l a r  
suppression o f  both FI and FR response rates . The present 
study con f i rms that c l ozapine produced s imi lar e f fects on 
the response duration measures ,  but the d i f ferent ial 
development of tolerance on the response rate and 
re inforcement rate measures appears incons i stent with 
8 2  
Leander ' s  f i ndings . It is important to note that the 
apparent discrepancy between Leander ' s  f indings and those 
of the present study may be due to d i f ferences in the 
species tested . 
The results from the POST/ PRE group ind icated that the 
tolerance to the initial disruption produced by presess ion 
c l o z ap ine inj ections cannot be exp l a ined by phys iological 
changes that occur due to repeated administration of the 
drug . These results a l so suggest that the initial 
d i srupt ion i s  not entirely due to the sedat ive propert ies 
o f  c l o z ap ine i if the disruption were s imply due to the 
sedat ive e f fects of c l ozapine , as suggested by an early 
study in this l aboratory ( V i l l anueva & Porter , 1 9 8 7 b ) , 
l ittle or no d is ruption should be produced by a presession 
inj ection o f  c l o z apine a fter nine days o f  post-session 
drugging ( i . e . , behavioral tolerance study ) . 
The lack o f  sign i f icant d i fferences in the amount of 
c l o z apine in the plasma of the three c l ozapine groups 
further supports the hypothes i s  that the development of 
tolerance to clozapine i s  primarily due to functional 
mechanisms . Both the chron ic ( day 1 0 )  and POST/PRE ( day 1 9 )  
groups d i spl ayed tolerance to the behavioral e f fects o f  
c l o z apine , whi l e  the behavior o f  the acute group ( first 
inj ect ion day ) was s igni ficantly decreased by the same 
concentration of c l ozapine in the bl oodstream . Further ,  the 
HPLC assays indicated no s ign i f icant d i f ferences between 
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the three c l o z apine groups . These find ings suggest that the 
development of d i spos it ional tolerance ( i .  e . , metabol i sm 
o f  the drug ) does not account for the tol erance to 
c l o z ap ine ' s  e f fects , further suggesting that functional 
mechanisms p l ay a role .  
One type o f  functional tolerance i s  behaviora l 
tolerance . Dews ( 19 7 8 )  def ines behavioral tolerance as the 
resul t  of a change in the e f f i cacy of the drug due to an 
a lteration of environmental constra ints . Accord ing to 
studies by S chuster and Z immerman , ( 1 9 6 1 ) , behavioral 
tolerance devel ops only when the d isruptive e f fects of a 
drug produce a decrease in reinforcement rates . S ince both 
the FI and FR schedules are response cont ingent schedules 
with rein forcement dependent upon a certain rate of 
respond ing , the devel opment of behavioral tol erance i s  
possible on e ither schedule .  FR re inforcement rate , 
however ,  possesses a greater dependency on response rate 
than does FI responding and thus should be more suscept ibl e 
to the devel opment o f  behaviora l tolerance . However , the 
present study observed the devel opment of behav ioral 
tolerance to c l ozapine on the FI schedul e ,  but did not 
observe tol erance to the e ffects of clozapine on the FR 
schedu l e . There are a number of possible expl anations for 
thi s  d i f ferent i a l  development of tolerance . One possib i l ity 
i s  that a l onger period of time is needed for the anima l s  
t o  develop tolerance t o  the d isruptive e f fects of clo zapine 
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on FR responding , as there was a nonsign i f icant trend 
toward recovery for the response rate and re inforcement 
rate measures . 
Two maj or hypotheses have been devel oped to attempt to 
exp l a i n  the cause of the rate d isrupting e f fects of 
neuroleptics . These hypotheses are the motor deficit 
hypothes i s  ( see Ettenberg et a l . ,  1 9 8 1 ;  Fibiger et a l . ,  
1 9 7 6 )  and the anhedon ia hypothes is ( see Wise , 1 9 8 2 ) . The 
motor deficit hypothes i s  suggests that the d isruption of 
operant responding occurs because neuroleptics produce 
extrapyramidal motor e f fects which render the subj ect 
incapable of responding . The a nhedoni a  hypothes is suggests 
that the subj ect no longer responds for rein forcement 
because neuroleptics reduce the reward va lue of the 
reinforcer . The lack of complete recovery on the FR 
schedul e  may be due to e ither a motor impa i rment or an 
a nhedoni c  e f fect . 
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The two schedules used i n  th is study required 
d i f ferenti a l  rates of responding to earn s im i l ar numbers of 
rei nforcers . Vehicle anima l s  responded at much higher rates 
on the FR schedul e  ( 8 0 - 1 0 0  responses/minute ; see Figure 4 )  
than on the FI schedul e  ( 4 0- 5 0  responses/minute ; see Figure 
1 ) . C l o z ap ine anima l s , therefore , had to respond at higher 
rates on the FR schedule to reach veh icle l evels . 
Furthermore , the absolute rates of respond ing for the 
c l o z apine animal s  on both the FI and FR schedule were 
nearly identi ca l , suggest ing that the subj ects were 
recovering at the same rate to both schedules , but a motor 
deficit may have been preventing recovery to the extremely 
high response rate l evel produced by the vehicle group . 
other research comparing the e ffects of neurol eptics on 
d i fferent response requirements suggests that neurolept ics 
have a greater e ffect on tasks which are kinetica l l y  more 
demand ing . Ettenberg et a l . ,  ( 1 9 8 1 )  found that when rats 
are tra ined to e ither nose poke or lever press for bra in 
stimu l ation , only the l ever press ing act ivity i s  disrupted 
by neurol eptics . 
I n  contrast , response duration results for the FR 
schedul e  were ident ical to the FI response duration 
results , indicating that tol erance devel oped to the 
c l o z ap ine ' s  initial d isruption o f  FR response durat ion . 
Fowler and coll eagues ( e . g . , Faustman & Fowle r ,  1 9 8 1 ;  
Wal ker , Faustman , Fowler & Kazar , 1 9 8 1 )  suggest that 
response durat ion may prov ide a better index of motor 
impai rment than s impl e  response rates . In the present 
experiment , anima l s  rece iv ing chronic presess ion c l ozapine 
developed tolerance to the response duration measure but 
not to the response rate measure when respond ing on the FR 
schedule . These results suggest that a motor impa irment , as 
measured by response duration , does not account for the 
rate disrupting e ffects of clozapine . 
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Fibiger and col leagues ( 19 7 6 )  have suggested that the 
motor d is ruption produced by clozapine is caused by a 
d i f f iculty in init iat ing voluntary movements . Response 
durat ion only measures the l ength of t ime the l ever is 
depressed , thus measuring the t ime it takes to terminate 
the movement . It is possible that d i f ferent mechanisms are 
responsib l e  for the initiation and termination of 
movements ,  and that tolerance i s  devel oping to the 
mechanism a f fecting response termination , but not response 
i n it iation . 
An a lternative explanation to the motor deficit 
hypothes i s  i s  the anhedon ia hypothes is ( see Wise , 1 9 8 2 ) . 
Thi s  hypothes i s  attributes the decrease in operant 
responding produced by neuroleptics to a decrease in reward 
value of the st imulus . Th is decrease in reward value has 
been demonstrated by comparing the e f fects o f  ant ipsychot ic 
drug administration to the e ffects o f  extinction . Wise and 
col leagues ( e . g . , Fouriezos & Wise , 1 9 7 6 :  Wise , Spindler & 
Legault , 1 9 7 8 : Wise , Spindler , Dewit & Gerber , 1 9 7 8 ) have 
shown that the e f fects of these two condit ions are s imi l ar . 
Ettenberg and col l eagues ( Camp & Ettenberg , 1 9 8 4 : Ettenberg 
and Camp , 1 9 8 6 )  have found s imilar results by generating a 
" pa rt i a l  re inforcement extinct ion e f fect" , which 
demonstrated that runway responses of anima l s  experiencing 
interm ittent food reward during the rein forcement phase of 
the experiment were more res istent to ext inction than were 
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continuousl y  reinforced anima l s . Intermittent treatment 
with haloperidol , a typical neuroleptic compound , produced 
a part i a l  rei nforcement extinct ion e ffect that was not 
d i f ferent from the e ffect produced by ext inction . stud ies 
i n  our l aboratory have produced s im i l ar results w ith 
haloperidol ( Porter , Wiley & Faw , 1 9 8 8 ) . Studies us ing 
c l o z ap ine in operant procedures have fa i led to f i nd 
a nhedoni c  e ffects ( see Faustman and Fowle r ,  1 9 8 2 ) . A recent 
study attempt ing to generate the partial re in forcement 
ext inction e ffect us ing c l ozapine (Wiley ,  1 9 8 8 ) found that 
c l o z ap ine does not block the re inforcing qual ity of the 
food rei n forcer , provid ing further evidence that c l ozapine 
does not produce patterns of behavior consistent with the 
anhedon i a  hypothes i s . Th is suggests that the l ack of 
tolerance to c l o z apine is not due to an anhedoni c  e f fect . 
C l o z apine ' s  behavioral e f fects , there fore , do not seem 
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to be attributable to e ither an anhedonic e f fect or a motor 
e f f ect involving a response termination deficit . other 
putat ive motor deficit s , however ,  such as Fibiger and 
col leagues ' ( 19 7 6 )  response init iation def i c it are not 
d iscounted by these results . Fina l l y ,  it is important to 
note that c l o z apine ' s  e f fects on other neurotransmitter 
systems ( e . g .  acetylchol ine , norepinephrine ) may mask the 
behavioral express ion of ant idopaminergic e f fects such a s  
a nhedonia a n d  motor disruption . 
Pimoz ide 
Whi l e  tolerance did not develop to the e f fects of 
p imo z ide , the oppos ite e f fect , increased sens itiv ity , was 
evident . The p imoz ide group demonstrated an increased 
behavioral sens itivity to the drug ' s  e ffects , with the 
disrupt ion of the FI response rate and response duration 
increasing over the 1 0  days . Results from the IOC data were 
in agreement w ith Kaempf and Porter ' s  ( 19 8 7 ) f inding that 
p imoz ide did not s ign i f icantly disrupt the " FI scal lop" 
pattern o f  responding . As a result , the decrease in the 
number of FI reinforcers earned , whi l e  s ign i f icant , was 
very smal l .  Pimo z ide , there fore , appears to d isrupt the 
operant response rates of the anima l s , but not the ir 
abi l ity to " t ime " , and thus , to respond correctly for food 
reinforcement on a f ixed interval schedule . Graml ing ,  
Fowler and Col l ins ( 19 8 4 )  also found that pimoz ide treated 
anima l s  l icking sucrose solutions produced a slowed , but 
essent i a l ly " norma l "  pattern of responding . Thi s  suggests 
that d i f ferent mechanisms are a f fected by the two drugs , 
one a f fect ing motor abil ity and one a f fect ing the abi l ity 
of the animal to produce the correct pattern of respond ing 
( i . e . , a t iming deficit ) . 
Leander ' s  study ( 19 8 3 )  comparing the d i f ferential 
e f fects of neuroleptics in pigeons responding on FI and FR 
schedules suggests that typ ical neurolept ics d isrupt FI 
response rates to a greater extent than FR response rates . 
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The present study found s imilar l evels o f  disrupt ion of 
both FI and FR response rates by p imoz ide for both the 
chronic presession and POST/PRE presession anima l s , with 
p imoz ide sign i f icantly suppress ing response rates and 
continuing to show an increas ing suppress ion over the ten 
days of chronic dos ing . There was , however , a d i f ferent ial 
d i s ruption o f  FI and FR re in forcers due to the high 
corre l at ion between response rate and the number of 
reinforcers earned on an FR schedule .  Pimoz ide 
s ign i f i cantly disrupted rein forcement rate on both 
schedules , however ,  the disruption of FI re in forcement rate 
was only 1 1 %  (mean vehicle re inforcement rate = 2 1 . 5 7 ,  
pimoz ide = 1 9 . 1 6 )  whi l e  the disruption o f  the FR 
reinforcement rate was 7 9 %  ( mean vehicle re inforcement rate 
2 7 . 2 9 ,  pimoz ide = 5 . 6 1 ) . 
As with the clozapine data , the p imoz ide data revealed 
that n ine days o f  post-session drug administration had 
l ittle e f fect on the fol l owing ten days of presession drug 
admin i stration . The fact that the post-session inj ections 
had l ittle e f fect on subsequent presession administration 
suggests that the increased sensit ivity to pimoz ide over 
t ime i s  not solely due to an accumulat ion of the drug . 
Pimo z ide i s  known to have a l ong hal f - l i fe ( up to 5 6  hours 
in rat l iver ; Pinder et a l . ,  197 6 ) , there fore there is 
l ikel y  to be a sUbstant ial accumulation of the drug over a 
n ine day period o f  post-sess ion drug administrat ion . 
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However ,  an increas ing motor deficit due to increas ing drug 
l evel s  cannot explain the increased sensitivity produced by 
p imoz ide ( i . e . , the cont inued decrease in responding over 
sess ions ) because post-session drug administration did not 
produce this sens itivity . I nstead , an interact ion between 
the drug and the behavior must occur to produce the 
sens itiv ity e f fect . 
Stud ies by Ante lman et a l . ( 19 8 3 ; 1 9 8 6 )  have suggested 
that the development of sensitivity to numerous compounds 
includ ing some neuroleptics is due not to repeated drug 
administrat ion , but due s imply to the passage of time . 
Ante lman and col l eagues ( 19 8 3 ; 1 9 8 6 )  have used the term 
" t ime-dependent sensitization" to explain this e f fect , and 
have found that a s ingl e  pretreatment with haloperidol or 
fluphenaz ine hydrochl oride i s  suf ficient to sens itize a 
cata l ept ic response to a second treatment . Thi s  second 
treatment may be given up to eight weeks l ater in the case 
o f  f luphena z ine hydrochloride . Antelman and col l eagues 
( 19 8 6 )  suggest that neuroleptic- induced sens itization , 
there fore , i s  not dependent on repeated drug treatment and 
exp l a i n  the ir f ind ings by suggesting that dopamine 
antagonistic propert ies continue to increase a fter acute 
neurol ept i c  treatment , even a fter the drug is no longer 
detectable . 
The present results are not cons istent with a time­
dependent sens i t i z ation for pimoz ide treatment . If the 
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increase in sensitivity to pimoz ide ' s  e ffects were solely 
due to the passage of time , the post-sess ion administration 
o f  pimoz ide should have produced an increas ing d i srupt ion 
o f  operant responding . Post-sess ion p imoz ide , however , had 
no s igni f i cant e f fects on operant respond ing , nor did it 
e f fect the subsequent presession results as compared to the 
chronic p imoz ide group ( presess ion administration only) . 
Thi s  suggests that the sens itivity the pimoz ide i s  not 
t ime-dependent , but is dependent on repeated drug 
adm i n i stration and is a f fected by functional mechanisms . 
Chronic p imoz ide administration in an operant schedule 
appears to produce a "behav ioral sensitivity" . 
The anhedonia hypothesis may be used to explain the 
cont inued decrease in operant responding observed with 
chroni c  pimoz ide administration . The continued decrease in 
respond ing over time produced a pattern s imi lar to the 
pattern produced by extinct ion . Wise and col l eagues have 
used a number of re in forc ing stimul i to compare the e f fects 
of nonreward and pimoz ide treatment ( Fouriezos & Wise , 
1 9 7 6 ;  Wise , Spindler & Legault , 1 9 7 8 ; Wise , Spindl er , Dewit 
& Gerber , 1 9 7 8 ) , demonstrat ing that both extinction and 
pimoz ide produce a s imilar d isrupt ion of respond ing . 
Faustman and Fowler ( 1 9 8 2 )  a l so found th is extinction- l ike 
pattern in response to pimoz ide on a continuous 
re in forcement schedul e .  Stud ies wh ich have f a i l ed to find 
the ext inct ion-l ike pattern in response to chronic pimoz ide 
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administration d i f fer in one of two important ways from the 
present study . Such studies e ither uti l i ze d i f ferent 
procedures ( e . g . , response requ i rements , deprivation 
procedures ) or d i f ferent neuroleptics ( e . g . , hal operidol , 
fluphenaz ine ) . These d i fferences may account for the 
d i f fering results . 
The present study suggests that a nhedonic propert ies 
may be important in the suppress ion of response rates by 
p imoz ide . In part icu l a r ,  the l ack of disruption during 
post-sess ion pimoz ide and the l ack o f  disruption of the 
pattern of respond ing ( IOC) suggest that pimoz ide ' s  
increased d isrupt ion o f  responding over t ime i s  not due 
s imply to carry-over motor e f fects , but that some 
interaction is necessary between the drug and the operant 
context . 
Summary and Conc lus ions 
The d i f ferent ial e f fects of p imoz ide and clozapine on 
this multiple schedule may be due to the d i f ferent ial 
e f fects o f  these drugs in the nervous system . Whi l e  
p imoz ide i s  a rel ative ly pure dopamine antagon ist , 
c l o z apine b inds to a variety of sites in the bra in 
includ ing dopamine , acetylchol ine and norepinephrine 
receptors . These multiple e ffects of clozapine may mask 
some of the anhedonic and motor e f fects of th is drug 
( Picka r ,  1 9 8 6 ) . 
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Further d i fferences between c l o z apine and pimoz ide are 
apparent in the spec i f i c  dopamine systems a l tered by these 
drugs . Blockade of the mesol imbic/mesocort ical pathway may 
be respons ible for the antipsychotic e ffect of 
neurol eptics , whereas blockade of the nigrostriatal pathway 
may be respons ible for the motor s i de e ffects ( Picka r ,  
1 9 8 6 ) . Wh i l e  the biochemical results from the present 
experiment did not reveal that clozapine d i f ferential ly 
b inds to s ites on the mesol imbic/mesocortical pathways , a 
previous b i ochemical study (Vi l lanueva et a l . ,  1 9 8 8 ) 
ind icated that cloz apine is present in greater 
concentrat ions in the frontal cortex than in the striatum . 
The b i ochemical study by Vi l lanueva et a l . ( 19 8 8 ) , however ,  
did not inc lude operant tra ining which may account for the 
d i f ferent results . 
The anhedonia hypothesis can be used to exp l a in the 
e f fects of p imoz ide on operant behavior , but not the 
e ffects of cloz apine . Thi s  supports the more conclus ive 
f ind ings of Wi ley ( 1 9 8 8 )  which determ ined that c l ozapine 
does not bl ock the reward value of the re in forcer . The rate 
disrupt ing e f fects of clozapine , may be due to e ither a 
motor e f fect or to some unknown interact ion between the 
drug and the operant schedul e .  Regardless of the cause of 
the disrupt ion of operant response rates , an interact ion 
between the drug and the environment i s  necessary for 
tolerance to devel op .  
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Functional mechani sms are responsible for both the 
devel opment of tol erance to clozapine and the devel opment 
of increased sens itivity to pimoz ide . I ncreased sens itivity 
to p imoz ide cannot be exp l a ined by t ime-dependent 
sens i t i z ation ( Antelman et a l . ,  1 9 8 6 ) , nor can it be 
expl a i ned by an increas ing accumulation of the drug . This 
increasing sens itivity to pimoz ide i s  a "behav iora l 
sens itivity" wh ich occurs only when the drug e f fects are 
paired with the operant sess ion . 
Because there i s  a high correlation between the 
antipsychot ic propert ies and the motor s ide e f fects of 
typ ical antipsychot ic compounds ,  current screen ing 
procedures for antipsychot ic drugs ( e . g . , the rotational 
model , the stereotypy model and the catalepsy test) involve 
the assessment of motor defic its . It is necessary to seek 
screening procedures wh ich assess other qua l ities of 
ant ipsychot ic compounds , s ince atypical ant ipsychot ics 
often have l ittle or no e f fect on motor impa i rment . A 
multiple schedul e  of re in forcement involving components 
with d i f ferent response cont ingenc ies ( such as this FI/FR 
schedu l e )  may be useful for identi fying atypical 
neuro l eptic compounds , especially if the two schedules 
requ ire d i f ferent levels of motor output and if an 
independent measure of motor abil ity , such as response 
duration , is included in addition to the trad it iona l 
measures of response rate and re inforcement rate . 
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Further stud ies are needed to determine i f  cloz apine ' s  
d i f ferent ial development of tolerance to the two schedules 
i s  a characteristic typical of other atypical 
ant ipsychotics , and if this characteristic i s  exclusive to 
antipsychot ic compounds .  Additional b iochemical stud ies to 
measure d i f ferent ial levels of neuroleptics on the 
n igrostriatal and mesol imbic/cortical pathways and to 
determine if these l evel s  are altered by operant tra ining 
would a l so be bene f icial . Final ly , concurrent 
admini strat ion of typical neuroleptics and antichol inergic 
compounds is suggested to determine whether the 
anticho l i nergic e f fects of clozapine are responsible for 
the d i f ferences between clozapine and pimo z ide . 
9 6  
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